Publications

2022

Fadel, M. G., Ahmed, M., Malietzis, G., Pellino, G., Rasheed, S., Brown, G., . . . Kontovounisios, C. (2022). Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review. CANCER TREATMENT REVIEWS, 109, 10 pages. doi:10.1016/j.ctrv.2022.102419

Hodges, N., Battersby, N., Rao, S., Brown, G., & TRIGGER Study Group. (2022). Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.. Ann Surg Oncol. doi:10.1245/s10434-022-11914-5

Rokan, Z., Simillis, C., Kontovounisios, C., Moran, B., Tekkis, P., & Brown, G. (2022). Locally Recurrent Rectal Cancer According to a Standardized MRI Classification System: A Systematic Review of the Literature. JOURNAL OF CLINICAL MEDICINE, 11(12), 16 pages. doi:10.3390/jcm11123511

Lord, A. C., Corr, A., Chandramohan, A., Hodges, N., Pring, E., Airo-Farulla, C., . . . Brown, G. (2022). Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.. Lancet Oncol, 23(6), 793-801. doi:10.1016/S1470-2045(22)00214-5

Hodges, N., Mackenzie, H., D’Souza, N., Brown, G., & Miskovic, D. (2022). Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study. EJSO, 48(4), 841-849. doi:10.1016/j.ejso.2021.10.007

Fernandes, M. C., Gollub, M. J., & Brown, G. (2022). The importance of MRI for rectal cancer evaluation.. Surg Oncol, 101739. doi:10.1016/j.suronc.2022.101739

Robb, H., Scrimgeour, G., Boshier, P., Przedlacka, A., Balyasnikova, S., Brown, G., . . . Kontovounisios, C. (2022). The current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 14 pages. doi:10.1007/s00464-022-09176-z

2021

Huddy, J. R., Rasheed, S., Brown, G., & Tilney, H. S. (2021). Comment on “Cancer Surgery During COVID-19: How We Move Forward”. ANNALS OF SURGERY, 274(6), E827-E828. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000718532600217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Robb, H. D., Scrimgeour, G., Boshier, P. R., Balyasnikova, S., Brown, G., Bello, F., & Kontovounisios, C. (2021). Current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review protocol. BMJ OPEN, 11(10), 4 pages. doi:10.1136/bmjopen-2020-045546

Brouwer, N. P. M., Lord, A. C., Terlizzo, M., Bateman, A. C., West, N. P., Goldin, R., . . . Brown, G. (2021). Interobserver variation in the classification of tumor deposits in rectal cancer-is the use of histopathological characteristics the way to go?. VIRCHOWS ARCHIV, 479(6), 1111-1118. doi:10.1007/s00428-021-03197-0

Tan, J. J., V. Carten, R., Babiker, A., Abulafi, M., Lord, A. C., & Brown, G. (2021). Prognostic Importance of MRI-Detected Extramural Venous Invasion in Rectal Cancer: A Literature Review and Systematic Meta-Analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 111(2), 385-394. doi:10.1016/j.ijrobp.2021.05.136

Rao, S., Guren, M. G., Khan, K., Brown, G., Renehan, A. G., Steigen, S. E., . . . Arnold, D. (2021). Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 32(9), 1087-1100. doi:10.1016/j.annonc.2021.06.015

Day, N., D’Souza, N., Shaw, A., Lord, A., Abulafi, M., Moran, B., . . . Brown, G. (2021). Local recurrence in sigmoid cancer is a hidden problem, could CT prognostic factors be of value in their prevention? A multi-centre study of 414 patients. EJSO, 47(8), 2093-2099. doi:10.1016/j.ejso.2021.03.254

Lord, A., Brown, G., Abulafi, M., Bateman, A., Frankel, W., Goldin, R., . . . Nagtegaal, I. (2021). Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus study. HISTOPATHOLOGY, 79(2), 168-175. doi:10.1111/his.14344

Rokan, Z., Simillis, C., Kontovounisios, C., Moran, B. J., Tekkis, P., & Brown, G. (2021). Systematic review of classification systems for locally recurrent rectal cancer. BJS OPEN, 5(3), 14 pages. doi:10.1093/bjsopen/zrab024

2020

Huddy, J. R., Tilney, H. S., Rasheed, S., Rasheed, S., Tilney, H. S., & Brown, G. (2020). Comment on “Cancer Surgery During COVID-19: How we Move Forward”.. Ann Surg. doi:10.1097/SLA.0000000000004544

Lord, A. C., DʼSouza, N., Shaw, A., Rokan, Z., Moran, B., Abulafi, M., . . . Brown, G. (2020). MRI-Diagnosed Tumour Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer.. Ann Surg. doi:10.1097/SLA.0000000000004499

Huddy, J. R., Rasheed, S., Brown, G., & Tilney, H. S. (2020). Letter to the Editor RE: “COVID-19 Impact on Colorectal Daily Practice-How Long Will It Take to Catch Up?”. JOURNAL OF GASTROINTESTINAL SURGERY, 24(11), 2696-2697. doi:10.1007/s11605-020-04795-0

D’Souza, N., Lord, A., Shaw, A., Patel, A., Balyasnikova, S., Tudyka, V., . . . Brown, G. (2020). The sigmoid take-off: An anatomical imaging definition of the rectum validated on specimen analysis. EJSO, 46(9), 1668-1672. doi:10.1016/j.ejso.2020.01.008

Keller, D. S., Berho, M., Brown, G., Hull, T., Moeslein, G., & Wexner, S. D. (2020). A narrative celebrating the recent contributions of women to colorectal surgery. SURGERY, 168(3), 355-362. doi:10.1016/j.surg.2020.06.024

Lord, A. C., Knijn, N., Brown, G., & Nagtegaal, I. D. (2020). Pathways of spread in rectal cancer: a reappraisal of the true routes to distant metastatic disease. EUROPEAN JOURNAL OF CANCER, 128, 1-6. doi:10.1016/j.ejca.2019.12.025

Glynne-Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rodel, C., Cervantes, A., & Arnold, D. (2017). Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 28, 22-40. doi:10.1093/annonc/mdx224

Khakoo, S., Carter, P. D., Brown, G., Valeri, N., Picchia, S., Bali, M. A., . . . Cunningham, D. (2020). MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer. CLINICAL CANCER RESEARCH, 26(1), 183-192. doi:10.1158/1078-0432.CCR-19-1996

Lord, A. C., Moran, B., Abulafi, M., Rasheed, S., Nagtegaal, I. D., Terlizzo, M., & Brown, G. (2020). Can extranodal tumour deposits be diagnosed on MRI? Protocol for a multicentre clinical trial (the COMET trial). BMJ OPEN, 10(10), 7 pages. doi:10.1136/bmjopen-2019-033395

Sclafani, F., Wilson, S. H., Cunningham, D., De Castro, D. G., Kalaitzaki, E., Begum, R., . . . Chau, I. (2020). Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. INTERNATIONAL JOURNAL OF CANCER, 146(1), 94-102. doi:10.1002/ijc.32507

2019

D’Souza, N., Babberich, M. P. M. D. N. T., d’Hoore, A., Tiret, E., Xynos, E., Beets-Tan, R. G. H., . . . Brown, G. (2019). Definition of the Rectum An International, Expert-based Delphi Consensus. ANNALS OF SURGERY, 270(6), 955-959. doi:10.1097/SLA.0000000000003251

D’Souza, N., Shaw, A., Lord, A., Balyasnikova, S., Abulafi, M., Tekkis, P., & Brown, G. (2019). Assessment of a Staging System for Sigmoid Colon Cancer Based on Tumor Deposits and Extramural Venous Invasion on Computed Tomography. JAMA NETWORK OPEN, 2(12), 11 pages. doi:10.1001/jamanetworkopen.2019.16987

Lord, A. C., Martinez, C. G., D’Souza, N., Pucher, P. H., Brown, G., & Nagtegaal, I. D. (2019). The significance of tumour deposits in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis. EUROPEAN JOURNAL OF CANCER, 122, 1-8. doi:10.1016/j.ejca.2019.08.020

Davidson, M., Aronson, L. I., Howard-Reeves, J., Bryant, H., Cutts, R. J., Hulkki-Wilson, S., . . . Chong, I. Y. (2019). Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme. EUROPEAN JOURNAL OF CANCER, 122, 12-21. doi:10.1016/j.ejca.2019.09.003

D’Souza, N., Lord, A. C., Shaw, A., Patel, A., Balyasnikova, S., Tudyka, V., . . . Brown, G. (2019). Ex vivo specimen MRI and pathology confirm a rectosigmoid mesenteric waist at the junction of the mesorectum and mesocolon. COLORECTAL DISEASE, 22(2), 212-218. doi:10.1111/codi.14856

Lord, A., D’Souza, N., Shaw, A., Day, N., & Brown, G. (2019). The Current Status of Nodal Staging in Rectal Cancer. CURRENT COLORECTAL CANCER REPORTS, 15(5), 143-148. doi:10.1007/s11888-019-00441-3

Vallance, A. E., Harji, D., & Fearnhead, N. S. (2019). Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer. EJSO, 45(9), 1567-1574. doi:10.1016/j.ejso.2019.04.005

Kennedy, E. D., Simunovic, M., Jhaveri, K., Kirsch, R., Brierley, J., Drolet, S., . . . Baxter, N. N. (2019). Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary Surgery The Phase 2 Nonrandomized QuickSilver Clinical Trial. JAMA ONCOLOGY, 5(7), 961-966. doi:10.1001/jamaoncol.2019.0186

Keller, D. S., & Brown, G. (2019). Invited editorial re: “Response assessment after (chemo) radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?”. EJSO, 45(6), 929-930. doi:10.1016/j.ejso.2018.12.013

West, M. A., Astin, R., Moyses, H. E., Cave, J., White, D., Levett, D. Z. H., . . . Jack, S. (2019). Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer. ACTA ONCOLOGICA, 58(5), 588-595. doi:10.1080/0284186X.2019.1566775

Pooni, A., Al-Sukhni, E., Milot, L., Fruitman, M., Victor, J. C., Schmocker, S., . . . Kennedy, E. (2019). Selection of Patients With Rectal Cancer for Preoperative Chemoradiotherapy: Are T Category and Nodal Status All That Matters?. DISEASES OF THE COLON & RECTUM, 62(4), 447-453. doi:10.1097/DCR.0000000000001229

D’Souza, N., Lord, A., Shaw, A., Abulafi, M., Kontovounisios, C., Sjovall, A., . . . Brown, G. (2019). Meta-analysis of oncological outcomes of sigmoid cancers: A hidden epidemic of R1 “palliative” resections. EJSO, 45(4), 489-497. doi:10.1016/j.ejso.2018.09.028

Balyasnikova, S., & Brown, G. (2019). The MRI assessment of SPECC (significant polyps and early colorectal cancer) lesions.. Colorectal Dis, 21 Suppl 1, 19-22. doi:10.1111/codi.14526

West, M. A., Astin, R., Moyses, H. E., Cave, J., White, D., Levett, D. Z. H., . . . Jack, S. (2019). Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.. Acta Oncol, 1-8. doi:10.1080/0284186X.2019.1566775

2018

Sclafani, F., Kalaitzaki, E., Cunningham, D., Tait, D., Brown, G., & Chau, I. (2018). Neoadjuvant rectal score: run with the hare and hunt with the hounds. ANNALS OF ONCOLOGY, 29(11), 2261-2262. doi:10.1093/annonc/mdy403

Siddiqui, M. R. S., Simillis, C., Bhoday, J., Battersby, N. J., Mok, J., Rasheed, S., . . . Brown, G. (2018). A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours. EUROPEAN JOURNAL OF CANCER, 104, 47-61. doi:10.1016/j.ejca.2018.07.131

D’Souza, N., Lord, A., Shaw, A., Abulafi, M., Kontovounisios, C., Sjövall, A., . . . Brown, G. (2018). Meta-analysis of oncological outcomes of sigmoid cancers: A hidden epidemic of R1 “palliative” resections.. Eur J Surg Oncol. doi:10.1016/j.ejso.2018.09.028

Patel, A., Rockall, A., Guthrie, A., Gleeson, F., Worthy, S., Grubnic, S., . . . Brown, G. (2018). Can the completeness of radiological cancer staging reports be improved using proforma reporting? A prospective multicentre non-blinded interventional study across 21 centres in the UK. BMJ OPEN, 8(10), 11 pages. doi:10.1136/bmjopen-2017-018499

Glynne-Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rödel, C., Cervantes, A., . . . ESMO Guidelines Committee. (2018). Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.. Ann Oncol, 29(Supplement_4), iv263. doi:10.1093/annonc/mdy161

Davidson, M., Nankivell, M., Cunningham, D., Starling, N., Koh, D. -M., Brown, G., . . . Riddell, A. (2018). Magnetic resonance imaging in oesophageal (oes) cancer: Results from the STO3 MRI substudy. In ANNALS OF ONCOLOGY Vol. 29 (pp. 1 page). Munich, GERMANY: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459277301217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Khakoo, S., Carter, P., Valeri, N., Shaikh, R., Jones, T., Begum, R., . . . Cunningham, D. (2018). Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer. In ANNALS OF ONCOLOGY Vol. 29 (pp. 661). Munich, GERMANY: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459277304231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Lord, A. C., D’Souza, N., Pucher, P. H., Moran, B. J., Abulafi, A. M., Wotherspoon, A., . . . Brown, G. (2018). Author response to comment on ‘significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis’. EUROPEAN JOURNAL OF CANCER, 105, 129-130. doi:10.1016/j.ejca.2018.08.018

D’Souza, N., Balyasnikova, S., Tudyka, V., Lord, A., Shaw, A., Abulafi, M., . . . Brown, G. (2018). Variation in landmarks for the rectum: an MRI study. COLORECTAL DISEASE, 20(10), O304-O309. doi:10.1111/codi.14398

D’Souza, N., Babberich, M. P. M. D. N. T., Lord, A., Shaw, A., Abulafi, M., Tekkis, P., . . . Brown, G. (2018). The rectosigmoid problem. SURGICAL ONCOLOGY-OXFORD, 27(3), 521-525. doi:10.1016/j.suronc.2018.06.005

Chand, M., Keller, D. S., Mirnezami, R., Bullock, M., Bhangu, A., Moran, B., . . . Berho, M. (2018). Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 10(7), 145-158. doi:10.4251/wjgo.v10.i7.145

Tekkis, P., Tait, D., Cunningham, D., & Brown, G. (2018). Is organ preservation in rectal cancer ready for prime time?. LANCET, 391(10139), 2480-2482. doi:10.1016/S0140-6736(18)31324-2

Sao Juliao, G. P., Ortega, C. D., Vailati, B. B., Coutinho, F. A. B., Rossi, G., Habr-Gama, A., . . . Perez, R. O. (2018). The Estimate of the Impact of Coccyx Resection in Surgical Field Exposure During Abdominal Perineal Resection Using Preoperative High-Resolution Magnetic Resonance. WORLD JOURNAL OF SURGERY, 42(11), 3765-3770. doi:10.1007/s00268-018-4683-x

Bhoday, J., Glimelius, B., Tait, D., Glynne-Jones, R., Adams, R., & Brown, G. (2018). Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?. COLORECTAL DISEASE, 20, 97-99. doi:10.1111/codi.14088

Battersby, N. J., Perez, R. O., Baxter, N., Moran, B., & Brown, G. (2018). Session 4: Trying to augment response with chemotherapy: a triumph of hope over experience?. COLORECTAL DISEASE, 20, 100-102. doi:10.1111/codi.14089

Dattani, M., Marijnen, C., Moran, B., Tait, D., Cunningham, C., Rodriguez-Bigas, M., & Brown, G. (2018). Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?. COLORECTAL DISEASE, 20, 92-96. doi:10.1111/codi.14087

Read, J., Tekkis, P., Rullier, E., Nicholls, J., Mortensen, N., Marks, J., . . . Brown, G. (2018). Session 3: Many ways to organ preserve the rectum but which is correct?. COLORECTAL DISEASE, 20, 82-87. doi:10.1111/codi.14085

Patel, A., Chang, G., Wale, A., Chong, I., Rutten, H., Nicholls, J., . . . Brown, G. (2018). Session 3: Intra-operative radiotherapy – creating new surgical boundaries. COLORECTAL DISEASE, 20, 65-75. doi:10.1111/codi.14083

Balyasnikova, S., Vuong, T., Wale, A., Chong, I., Rutten, H., & Brown, G. (2018). Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?. COLORECTAL DISEASE, 20, 88-91. doi:10.1111/codi.14086

Patel, U. B., Blomqvist, L., Chau, I., Nicholls, J., & Brown, G. (2018). Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response. COLORECTAL DISEASE, 20, 76-81. doi:10.1111/codi.14084

Patel, A., Holm, T., Wale, A., Rutten, H., Nicholls, J., Hawkins, M., . . . Brown, G. (2018). Session 3: Beyond the boundaries of Total Mesorectal Excision – where surgeons fear to tread. COLORECTAL DISEASE, 20, 61-64. doi:10.1111/codi.14082

Siddiqui, M., Nagtegaal, I., Santiago, I., Knijn, N., Berho, M., Mirnezami, A., . . . Brown, G. (2018). Session 2: What causes liver metastases – lymph nodes or is it something else?. COLORECTAL DISEASE, 20, 39-42. doi:10.1111/codi.14077

Wale, A., Van Cutsem, E., Rao, S., Cunningham, D., & Brown, G. (2018). Session 2: Synchronous metastatic disease-liver first or primary first? The oncologist decides. COLORECTAL DISEASE, 20, 52-55. doi:10.1111/codi.14080

Siddiqui, M., Chand, M., Eng, C., Mehdizadeh, A., Mirnezami, A., & Brown, G. (2018). Session 2: Mutational discordance: the big challenge in personalized treatments – any solutions?. COLORECTAL DISEASE, 20, 49-51. doi:10.1111/codi.14079

Balyasnikova, S., Haboubi, N., Wale, A., Santiago, I., Morgan, M., Cunningham, D., . . . Brown, G. (2018). Session 2: Extramural vascular invasion and extranodal deposits: should they be treated the same?. COLORECTAL DISEASE, 20, 43-48. doi:10.1111/codi.14078

Patel, U. B., Cervantes, A., Fernandez-Martos, C., Sclafani, F., Cunningham, D., Nilsson, P., & Brown, G. (2018). Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?. COLORECTAL DISEASE, 20, 56-60. doi:10.1111/codi.14081

Bhoday, J., Martling, A., Strassburg, J., & Brown, G. (2018). Session 1: The surgeon as a prognostic factor in colon and rectal cancer?. COLORECTAL DISEASE, 20, 36-38. doi:10.1111/codi.14076

Wale, A., Wexner, S. D., Saur, N. M., Massarotti, H., Laurberg, S., Kennedy, E., . . . Brown, G. (2018). Session 1: The evolution and development of the multidisciplinary team approach: USA, European and UK experiences – what can we do better?. COLORECTAL DISEASE, 20, 17-27. doi:10.1111/codi.14073

Tudyka, V., Madoff, R., Wale, A., Laurberg, S., Yano, H., & Brown, G. (2018). Session 1: Colon cancer-10years behind the rectum. COLORECTAL DISEASE, 20, 28-33. doi:10.1111/codi.14074

Brown, G. (2018). Proceedings of the Future Horizons International Experts Meeting in Colorectal Cancer Held in London on 25th June 2015. Edited by: Dr Anita Wale and Prof Gina Brown. COLORECTAL DISEASE, 20, 5-7. doi:10.1111/codi.14068

Bernier, L., Balyasnikova, S., Tait, D., & Brown, G. (2018). Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. CURRENT COLORECTAL CANCER REPORTS, 14(2), 37-55. doi:10.1007/s11888-018-0398-5

Sclafani, F., Chau, I., Cunningham, D., Hahne, J. C., Vlachogiannis, G., Eltahir, Z., . . . Valeri, N. (2018). KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. SCIENTIFIC REPORTS, 8, 9 pages. doi:10.1038/s41598-018-19212-5

Chand, M., & Brown, G. (2018). Important imaging considerations in the pre-operative assessment of rectal cancer (Reprinted from Seminars in Colon and Rectal Surgery, vol 25, pg 6-12, 2014). SEMINARS IN COLON AND RECTAL SURGERY, 29(4), 199-205. doi:10.1053/j.scrs.2018.11.008

Lawler, M., Alsina, D., Adams, R. A., Anderson, A. S., Brown, G., Fearnhead, N. S., . . . Tomlinson, I. (2018). Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. GUT, 67(1), 179-193. doi:10.1136/gutjnl-2017-315333

Siddiqui, M., Balyansikova, S., Nagtegaal, I., West, N., Murray, G., Bosch, S., . . . Brown, G. (2018). Agreement between histopathologic regression and MRI Tumour Regression (mrTRG) scales used to assess response for rectal cancers. International Journal of Surgery. doi:10.1016/j.ijsu.2018.05.190

2017

Battersby, N. J., Moran, B., Stelzner, S., West, N. P., Branagan, G., Strassburg, J., . . . Brown, G. (2017). Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?. ANNALS OF SURGERY, 266(6), E116-E118. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000419022400092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Sclafani, F., Brown, G., Cunningham, D., Wotherspoon, A., Mendes, L. S. T., Balyasnikova, S., . . . Chau, I. (2017). Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. BRITISH JOURNAL OF CANCER, 117(10), 1478-1485. doi:10.1038/bjc.2017.320

Bhoday, J., Balyasnikova, S., Wale, A., & Brown, G. (2017). How Should Imaging Direct/Orient Management of Rectal Cancer?. CLINICS IN COLON AND RECTAL SURGERY, 30(5), 297-312. doi:10.1055/s-0037-1606107

Siddiqui, M. R. S., Shanmuganandan, A. P., Rasheed, S., Tekkis, P., Brown, G., & Abulafi, A. M. (2017). An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines. EJSO, 43(11), 2093-2104. doi:10.1016/j.ejso.2017.09.003

Lord, A. C., D’Souza, N., Pucher, P. H., Moran, B. J., Abulafi, A. M., Wotherspoon, A., . . . Brown, G. (2017). Significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis. EUROPEAN JOURNAL OF CANCER, 82, 92-102. doi:10.1016/j.ejca.2017.05.027

Sclafani, F., Brown, G., Cunningham, D., Wotherspoon, A., Mendes, L. S. T., Evans, J., . . . Chau, I. (2017). Comparison between magnetic resonance imaging (MRI) and pathology in the assessment of tumour regression grade (TRG) in rectal cancer (RC). In ANNALS OF ONCOLOGY Vol. 28 (pp. 2 pages). Madrid, SPAIN: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324004275&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Battersby, N. J., Dattani, M., Rao, S., Cunningham, D., Tait, D., Adams, R., . . . Brown, G. (2017). A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. TRIALS, 18, 14 pages. doi:10.1186/s13063-017-2085-2

Glynne-Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rodel, C., Cervantes, A., & Arnold, D. (2017). Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ANNALS OF ONCOLOGY, 28, 22-40. doi:10.1093/annonc/mdx224

Balyasnikova, S., Read, J., Wotherspoon, A., Rasheed, S., Tekkis, P., Tait, D., . . . Brown, G. (2017). Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ OPEN GASTROENTEROLOGY, 4(1), 9 pages. doi:10.1136/bmjgast-2017-000151

Sclafani, F., Brown, G., Cunningham, D., Rao, S., Tekkis, P., Tait, D., . . . Chau, I. (2017). Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy. ONCOLOGIST, 22(6), 728-736. doi:10.1634/theoncologist.2016-0396

Siddiqui, M. R. S., Simillis, C., Hunter, C., Chand, M., Bhoday, J., Garant, A., . . . Brown, G. (2017). A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. BRITISH JOURNAL OF CANCER, 116(12), 1513-1519. doi:10.1038/bjc.2017.99

Sugarbaker, P. H., Sardi, A., Brown, G., Dromain, C., Rousset, P., & Jelinek, J. S. (2017). Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 33(5), 497-504. doi:10.1080/02656736.2017.1317368

Patel, U. B., Brown, G., Machado, I., Santos-Cores, J., Pericay, C., Ballesteros, E., . . . Fernandez-Martos, C. (2017). MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. ANNALS OF ONCOLOGY, 28(2), 344-353. doi:10.1093/annonc/mdw616

Sclafani, F., Brown, G., Cunningham, D., Rao, S., Tekkis, P. P., & Tait, D. M. (2017). Systemic chemotherapy (CT) as salvage treatment for locally advanced rectal cancer (LARC) patients (pts) who fail to respond to neoadjuvant chemoradiotherapy (CRT).. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443281700690&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Hunter, C., Siddiqui, M., Delisle, T. G., Blake, H., Jeyadevan, N., Abulafi, M., . . . Brown, G. (2017). CT and 3-T MRI accurately identify T3c disease in colon cancer, which strongly predicts disease-free survival. CLINICAL RADIOLOGY, 72(4), 307-315. doi:10.1016/j.crad.2016.11.014

Georgiou, P. A., Ali, S. M., Brown, G., Rasheed, S., & Tekkis, P. P. (2017). Extended lymphadenectomy for locally advanced and recurrent rectal cancer. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 32(3), 333-340. doi:10.1007/s00384-016-2711-6

Ciombor, K. K., Ernst, R. D., & Brown, G. (2017). Diagnosis and Diagnostic Imaging of Anal Canal Cancer. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 26(1), 45-+. doi:10.1016/j.soc.2016.07.002

Balyasnikova, S., Haboubi, N., Moran, B., & Brown, G. (2017). Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies. TECHNIQUES IN COLOPROCTOLOGY, 21(1), 15-23. doi:10.1007/s10151-016-1555-y

Battersby, N. J., Moran, B., Stelzner, S., West, N. P., Branagan, G., Strassburg, J., . . . Brown, G. (2017). Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?. Ann Surg, 266(6), e116-e118. doi:10.1097/SLA.0000000000001791

Simillis, C., Baird, D. L. H., Kontovounisios, C., Pawa, N., Brown, G., Rasheed, S., & Tekkis, P. P. (2017). A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer. ANNALS OF SURGERY, 265(2), 291-299. doi:10.1097/SLA.0000000000001963

Balyasnikova, S., Read, J., Tait, D., Wotherspoon, A., Swift, I., Cunningham, D., . . . Brown, G. (2017). The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery. COLORECTAL DISEASE, 19(2), 139-147. doi:10.1111/codi.13477

2016

Harris, D. A., Thorne, K., Hutchings, H., Islam, S., Holland, G., Hatcher, O., . . . Beynon, J. (2016). Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). BMJ OPEN, 6(11), 8 pages. doi:10.1136/bmjopen-2016-012496

Frentzas, S., Simoneau, E., Bridgeman, V. L., Vermeulen, P. B., Foo, S., Kostaras, E., . . . Reynolds, A. R. (2016). Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. NATURE MEDICINE, 22(11), 1294-1302. doi:10.1038/nm.4197

Evans, J., Bhoday, J., Sizer, B., Tekkis, P., Swift, R., Perez, R., . . . Brown, G. (2016). Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?. ANNALS OF ONCOLOGY, 27, 1 page. doi:10.1093/annonc/mdw370.1

Sclafani, F., Chau, I., Cunningham, D., Vlachogiannis, G., Eltahir, Z., Lampis, A., . . . Valeri, N. (2016). KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial. ANNALS OF ONCOLOGY, 27, 1 page. doi:10.1093/annonc/mdw370.73

O’Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., . . . Waterton, J. C. (2017). Imaging biomarker roadmap for cancer studies. NATURE REVIEWS CLINICAL ONCOLOGY, 14(3), 169-186. doi:10.1038/nrclinonc.2016.162

Siddiqui, M. R. S., Bhoday, J., Battersby, N. J., Chand, M., West, N. P., Abulafi, A. -M., . . . Brown, G. (2016). Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. WORLD JOURNAL OF GASTROENTEROLOGY, 22(37), 8414-8434. doi:10.3748/wjg.v22.i37.8414

Lutz, M. P., Zalcberg, J. R., Glynne-Jones, R., Ruers, T., Ducreux, M., Arnold, D., . . . Otto, F. (2016). Corrigendum to “2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer” [Eur J Cancer 63 (August 2016) 11-24].. Eur J Cancer, 68, 208-209. doi:10.1016/j.ejca.2016.08.017

Battersby, N. J., How, P., Moran, B. J., Stelzner, S., West, N. P., Branagan, G., . . . Pedersen, B. G. (2016). The MERCURY II Study: Prospective Validation of a Low Rectal Cancer Assessment System Using Magnetic Resonance Imaging, and Development of a Local Recurrence Risk Stratification Model. In JOURNAL OF PATHOLOGY Vol. 240 (pp. 18). Univ Nottingham, Sch Med, Acad Univ Mol Pathol Div Canc & Stem Cells, Nottingham, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386691900075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Bhoday, J., Smith, F., Siddiqui, M. R., Balyasnikova, S., Swift, R. I., Perez, R., . . . Brown, G. (2016). Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy. DISEASES OF THE COLON & RECTUM, 59(10), 925-933. doi:10.1097/DCR.0000000000000667

Chand, M., Rasheed, S., Heald, R., Swift, I., West, N., Rao, S., . . . Brown, G. (2017). Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation. COLORECTAL DISEASE, 19(6), 537-543. doi:10.1111/codi.13535

Kontovounisios, C., Tan, E., Pawa, N., Brown, G., Tait, D., Cunningham, D., . . . Tekkis, P. (2017). The selection process can improve the outcome in locally advanced and recurrent colorectal cancer: activity and results of a dedicated multidisciplinary colorectal cancer centre. COLORECTAL DISEASE, 19(4), 331-338. doi:10.1111/codi.13517

Siddiqui, M. R. S., Gormly, K. L., Bhoday, J., Balyansikova, S., Battersby, N. J., Chand, M., . . . Brown, G. (2016). Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). CLINICAL RADIOLOGY, 71(9), 854-862. doi:10.1016/j.crad.2016.05.005

Pearson, A., Smyth, E., Babina, I. S., Herrera-Abreu, M. T., Tarazona, N., Peckitt, C., . . . Turner, N. C. (2016). High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial. CANCER DISCOVERY, 6(8), 838-851. doi:10.1158/2159-8290.CD-15-1246

Sclafani, F., Chau, I., Cunningham, D., Lampis, A., Hahne, J. C., Ghidini, M., . . . Valeri, N. (2016). Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients. CARCINOGENESIS, 37(9), 852-857. doi:10.1093/carcin/bgw073

Hunter, C., Blake, H., Jeyadevan, N., Abulafi, M., Swift, I., Toomey, P., & Brown, G. (2016). Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging. BRITISH JOURNAL OF RADIOLOGY, 89(1064), 9 pages. doi:10.1259/bjr.20160257

Balyasnikova, S., & Brown, G. (2016). Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 17(6), 11 pages. doi:10.1007/s11864-016-0403-7

Lutz, M. P., Zalcberg, J. R., Glynne-Jones, R., Ruers, T., Ducreux, M., Arnold, D., . . . Otto, F. (2016). Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. EUROPEAN JOURNAL OF CANCER, 63, 11-24. doi:10.1016/j.ejca.2016.04.010

Sclafani, F., Brown, G., Cunningham, D., Wotherspoon, A., Tait, D., Peckitt, C., . . . Chau, I. (2016). PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. ANNALS OF ONCOLOGY, 27(8), 1557-1565. doi:10.1093/annonc/mdw215

Hunter, C., & Brown, G. (2016). Pre-operative staging of rectal cancer: a review of imaging techniques. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 10(9), 1011-1025. doi:10.1080/17474124.2016.1179577

Battersby, N. J., How, P., Moran, B., Stelzner, S., West, N. P., Branagan, G., . . . Brown, G. (2016). Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study. ANNALS OF SURGERY, 263(4), 751-760. doi:10.1097/SLA.0000000000001193

Balyasnikova, S., & Brown, G. (2016). Imaging Advances in Colorectal Cancer. CURRENT COLORECTAL CANCER REPORTS, 12(3), 162-169. doi:10.1007/s11888-016-0321-x

West, M. A., Dimitrov, B. D., Moyses, H. E., Kemp, G. J., Loughney, L., White, D., . . . Brown, G. (2016). Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer – A comparison of magnetic resonance imaging at two time points and histopathological responses. EJSO, 42(9), 1350-1358. doi:10.1016/j.ejso.2016.04.003

Sclafani, F., & Brown, G. (2016). Extramural Venous Invasion (EMVI) and Tumour Regression Grading (TRG) as Potential Prognostic Factors for Risk Stratification and Treatment Decision in Rectal Cancer. CURRENT COLORECTAL CANCER REPORTS, 12(3), 130-140. doi:10.1007/s11888-016-0319-4

Siddiqui, M. R. S., Balyansikova, S., Bhoday, J., Chand, M., Rao, S., Tekkis, P., . . . Brown, G. (2016). MRI assessment of intraluminal and extramural regression after chemoradiation therapy. In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 18). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374301300046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Siddiqui, M. R. S., Bhoday, J., Balyansikova, S., Battersby, N. J., Gormly, K. L., Rao, S., . . . Brown, G. (2016). Inter-observer agreement of radiologists assessing the response of rectal cancers after chemoradiation therapy according to MRI tumour regression grading (mrTRG). In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 17). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374301300043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Siddiqui, M. R. S., Chand, M., Bhoday, J., Tekkis, P., Abulafi, A. M., & Brown, G. (2016). Correlation between MRI detected extra-mural vascular invasion (mrEMVI) in rectal cancer and metastatic disease: a meta-analysis. In BRITISH JOURNAL OF SURGERY Vol. 103 (pp. 19). Royal Coll Surg England, London, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374301300049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Hill, E. J., Roberts, C., Franklin, J. M., Enescu, M., West, N., MacGregor, T. P., . . . Sharma, R. A. (2016). Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer. CLINICAL CANCER RESEARCH, 22(8), 1922-1931. doi:10.1158/1078-0432.CCR-15-1489

Smyth, E. C., Turner, N. C., Pearson, A., Peckitt, C., Chau, I., Watkins, D. J., . . . Cunningham, D. (2016). Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2016.34.4_suppl.154

Chand, M., Siddiqui, M. R. S., Swift, I., & Brown, G. (2016). Systematic review of prognostic importance of extramural venous invasion in rectal cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 22(4), 1721-1726. doi:10.3748/wjg.v22.i4.1721

2015

Smyth, E. C., Turner, N., Pearson, A., Peckitt, C., Chau, I., Watkins, D., . . . Cunningham, D. (2015). Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results. In ANNALS OF ONCOLOGY Vol. 26 (pp. 44). Singapore, SINGAPORE: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367158700145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Tekkis, P., Tan, E., Kontovounisios, C., Kinross, J., Georgiou, C., Nicholls, R. J., . . . Brown, G. (2015). Hand-sewn coloanal anastomosis for low rectal cancer: technique and long-term outcome. COLORECTAL DISEASE, 17(12), 1062-1070. doi:10.1111/codi.13028

Machado, I., Patel, U., Brown, G., Salud, A., Gil, M., Montagut, C., . . . Fernandez-Martos, C. (2015). The prognostic significance of radiologic and pathologic factors after neoadyuvant chemotherapy for T3 rectal cancer (RC): 3-years update GEMCAD 0801 trial. In EUROPEAN JOURNAL OF CANCER Vol. 51 (pp. S387). Vienna, AUSTRIA: ELSEVIER SCI LTD. doi:10.1016/S0959-8049(16)31082-6

Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J. C., . . . Valeri, N. (2015). Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial. In EUROPEAN JOURNAL OF CANCER Vol. 51 (pp. S396). Vienna, AUSTRIA: ELSEVIER SCI LTD. doi:10.1016/S0959-8049(16)31107-8

West, M. A., Grocott, M. P. W., Jack, S., Kemp, G. J., & Brown, G. (2015). Exercise training response is associated with greater tumour regression in rectal cancer following neoadjuvant chemoradiotherapy. In BRITISH JOURNAL OF SURGERY Vol. 102 (pp. 55). Manchester, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368130400175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Hugen, N., Brown, G., Glynne-Jones, R., de Wilt, J. H. W., & Nagtegaal, I. D. (2016). Advances in the care of patients with mucinous colorectal cancer. NATURE REVIEWS CLINICAL ONCOLOGY, 13(6), 361-369. doi:10.1038/nrclinonc.2015.140

Sclafani, F., Chau, I., Cunningham, D., Peckitt, C., Lampis, A., Hahne, J. C., . . . Valeri, N. (2015). Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial. ANNALS OF ONCOLOGY, 26(9), 1936-1941. doi:10.1093/annonc/mdv285

Gollins, S., Sebag-Montefiore, D., Adams, R., Saunders, M. P., Grieve, R., Scott, N., . . . Hurt, C. (2015). A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). In JOURNAL OF CLINICAL ONCOLOGY Vol. 33 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036900828&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Sclafani, F., Peckitt, C., Cunningham, D., Tait, D., Giralt, J., Glimelius, B., . . . Chau, I. (2015). Short-and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(2), 303-312. doi:10.1016/j.ijrobp.2015.03.038

Chand, M., Palmer, T., Blomqvist, L., Nagtegaal, I., West, N., & Brown, G. (2015). Evidence for radiological and histopathological prognostic importance of detecting extramural venous invasion in rectal cancer: recommendations for radiology and histopathology reporting. COLORECTAL DISEASE, 17(6), 468-473. doi:10.1111/codi.12920

Machado, I., Brown, G., Estevan, R., Salud, A., Gil, M., Montagut, C., . . . Fernandez-Martos, C. (2015). Radiologic and pathologic prognostic factors after neoadyuvant chemotherapy for T3 rectal cancer (RC): 3-year update GEMCAD 0801-trial.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 33 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2015.33.3_suppl.643

Sclafani, F., Chau, I., Cunningham, D., Lampis, A., Hahne, J., Braconi, C., . . . Valeri, N. (2015). Prognostic effect of a single nucleotide polymorphism (SNP) in MIR608 in patients with high-risk locally advanced rectal cancer (LARC): Results of the EXPERT-C trial.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 33 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2015.33.3_suppl.581

2014

Slesser, A. A. P., Khan, F., Chau, I., Khan, A. Z., Mudan, S., Tekkis, P. P., . . . Rao, S. (2015). The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: An exploratory study. EJSO, 41(4), 484-492. doi:10.1016/j.ejso.2014.12.009

Chand, M., Balyasnikova, S., & Brown, G. (2015). The role of imaging in the diagnosis and staging of primary and recurrent rectal cancer. In Modern Management of Cancer of the Rectum (pp. 81-96). doi:10.1007/978-1-4471-6609-2_6

Rymer, B., Chand, M., Bhangu, A., Swift, I., & Brown, G. (2015). FDG-PET-CT can be used to Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy: Evidence from Meta-Analysis. In BRITISH JOURNAL OF SURGERY Vol. 102 (pp. 184-185). Harrogate, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346489701210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Siddiqui, M., Bhoday, J., Abulafi, M. A., Tekkis, P., & Brown, G. (2015). Defining Poor Response after Neoadjuvant Therapy in Patients with Rectal Cancer. In BRITISH JOURNAL OF SURGERY Vol. 102 (pp. 28). Harrogate, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346489700075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Messager, M., Brown, G., & Allum, W. H. (2014). MDCT for Staging of Oesophageal and Junctional Cancer: Do we need a Dedicated Reporting Template?. In BRITISH JOURNAL OF SURGERY Vol. 101 (pp. 38). Brighton, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345329400126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G., & Evans, J. (2014). Timing of surgery following chemoradiotherapy in rectal Cancer.. Indian J Med Paediatr Oncol, 35(4), 235-236. doi:10.4103/0971-5851.144959

Kontovounisios, C., Kinross, J., Tan, E., Brown, G., Rasheed, S., & Tekkis, P. (2015). Complete mesocolic excision in colorectal cancer: a systematic review. COLORECTAL DISEASE, 17(1), 7-16. doi:10.1111/codi.12793

Frentzas, S., Thompson, V. L., Vermeulen, P. B., Foo, S., Brown, G., Cunningham, D., & Reynolds, A. R. (2014). Vessel co-option in colorectal cancer liver metastases mediates resistance to VEGF-targeted therapy. In CANCER RESEARCH Vol. 74 (pp. 1 page). San Diego, CA: AMER ASSOC CANCER RESEARCH. doi:10.1158/1538-7445.AM2014-2997

2014

Khan, K., Wale, A., Brown, G., & Chau, I. (2014). Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone?. WORLD JOURNAL OF GASTROENTEROLOGY, 20(35), 12391-12406. doi:10.3748/wjg.v20.i35.12391

Chand, M., Evans, J., Swift, R. I., Tekkis, P. P., West, N. P., Stamp, G., . . . Brown, G. (2015). The Prognostic Significance of Postchemoradiotherapy High-resolution MRI and Histopathology Detected Extramural Venous Invasion in Rectal Cancer. ANNALS OF SURGERY, 261(3), 473-479. doi:10.1097/SLA.0000000000000848

Chand, M., Brown, G., Tekkis, P., & Heald, R. J. (2014). Total mesorectal excision optimized by pelvic MRI. COLORECTAL DISEASE, 16(11), 847-853. doi:10.1111/codi.12773

Fernandez-Martos, C., Brown, G., Estevan, R., Salud, A., Montagut, C., Maurel, J., . . . Pericay, C. (2014). Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial. ONCOLOGIST, 19(10), 1042-1043. doi:10.1634/theoncologist.2014-0233

Georgiou, P. A., Bhangu, A., Brown, G., Rasheed, S., Nicholls, R. J., & Tekkis, P. P. (2015). Learning curve for the management of recurrent and locally advanced primary rectal cancer: a single team’s experience. COLORECTAL DISEASE, 17(1), 57-65. doi:10.1111/codi.12772

Battersby, N. J., Balyasnikova, S., & Brown, G. (2014). Guiding Post-Treatment Decisions in Rectal Cancer: mrTRG Is a Practical Place to Start. ONCOLOGY-NEW YORK, 28(8), 677-680. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000340866000003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Wale, A., & Brown, G. (2014). A practical review of the performance and interpretation of staging magnetic resonance imaging for rectal cancer.. Top Magn Reson Imaging, 23(4), 213-223. doi:10.1097/RMR.0000000000000028

Sclafani, F., Gonzalez, D., Cunningham, D., Wilson, S. H., Peckitt, C., Tabernero, J., . . . Chau, I. (2014). TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106(7), 4 pages. doi:10.1093/jnci/dju121

Thompson, V., Frentzas, S., Vermeulen, P., Foo, S., Eltahir, Z., Brown, G., . . . Reynolds, A. R. (2014). Proffered Paper: Vessel co-option in colorectal cancer liver metastases mediates resistance to conventional anti-angiogenic therapy. EUROPEAN JOURNAL OF CANCER, 50, S9. doi:10.1016/S0959-8049(14)50032-9

Sclafani, F., de Castro, D. G., Cunningham, D., Wilson, S. H., Peckitt, C., Capdevila, J., . . . Chau, I. (2014). Fc gamma RIIa and Fc gamma RIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease. CLINICAL CANCER RESEARCH, 20(17), 4511-4519. doi:10.1158/1078-0432.CCR-14-0674

Bhangu, A., Rasheed, S., Brown, G., Tait, D., Cunningham, D., & Tekkis, P. (2014). Does rectal cancer height influence the oncological outcome?. COLORECTAL DISEASE, 16(10), 801-808. doi:10.1111/codi.12703

Chand, M., Siddiqui, M. R. S., Rasheed, S., Brown, G., Tekkis, P., Parvaiz, A., & Qureshi, T. (2014). A systematic review and meta-analysis evaluating the role of laparoscopic surgical resection of transverse colon tumours. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 28(12), 3263-3272. doi:10.1007/s00464-014-3634-3

Battersby, N. J., Moran, B., Yu, S., Tekkis, P., & Brown, G. (2014). MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 8(6), 703-719. doi:10.1586/17474124.2014.906898

Kennedy, E. D., Milot, L., Fruitman, M., Al-Sukhni, E., Heine, G., Schmocker, S., . . . McLeod, R. S. (2014). Development and Implementation of a Synoptic MRI Report for Preoperative Staging of Rectal Cancer on a Population-Based Level. DISEASES OF THE COLON & RECTUM, 57(6), 700-708. doi:10.1097/DCR.0000000000000123

Sclafani, F., Peckitt, C., Cunningham, D., Evans, J., Brown, G., Tabernero, J., . . . Chau, I. (2014). Panex: A pooled analysis of EXPERT and EXPERT-C, two trials of neoadjuvant chemotherapy (NACT) and chemoradiotherapy (CRT) in high-risk locally advanced rectal cancer (LARC).. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2014.32.15_suppl.3575

Watkins, D. J., Starling, N., Cunningham, D., Thomas, J., Webb, J., Brown, G., . . . Chau, I. (2014). The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study. EUROPEAN JOURNAL OF CANCER, 50(8), 1422-1429. doi:10.1016/j.ejca.2014.02.003

Chand, M., Bhangu, A., Wotherspoon, A., Stamp, G. W. H., Swift, R. I., Chau, I., . . . Brown, G. (2014). EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. ANNALS OF ONCOLOGY, 25(4), 858-863. doi:10.1093/annonc/mdu029

Chand, M., & Brown, G. (2014). Important imaging considerations in the pre-operative assessment of rectal cancer. Seminars in Colon and Rectal Surgery, 25(1), 6-12. doi:10.1053/j.scrs.2013.11.001

Bhangu, A., Kiran, R. P., Brown, G., Goldin, R., & Tekkis, P. (2014). Establishing the optimum lymph node yield for diagnosis of stage III rectal cancer. TECHNIQUES IN COLOPROCTOLOGY, 18(8), 709-717. doi:10.1007/s10151-013-1114-8

Bhangu, A., Ali, S. M., Brown, G., Nicholls, R. J., & Tekkis, P. (2014). Indications and Outcome of Pelvic Exenteration for Locally Advanced Primary and Recurrent Rectal Cancer. ANNALS OF SURGERY, 259(2), 315-322. doi:10.1097/SLA.0b013e31828a0d22

Khan, K. H., Wale, A., McCall, J., Wijesekera, N., Khan, N., Chau, I., & Brown, G. (2014). The impact of treatment intent on overall survival after radiofrequency ablation of colorectal cancer liver metastases: The Royal Marsden Hospital experience.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2014.32.3_suppl.622

Sclafani, F., Gonzalez, D., Cunningham, D., Wilson, S. H., Peckitt, C., Tabernero, J., . . . Chau, I. (2014). RAS mutations in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC).. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2014.32.3_suppl.489

Hill, E. J., Enescu, M., West, N., Franklin, J. M., Chu, K. -Y., Li, J., . . . Sharma, R. A. (2014). Oral nelfinavir before and during radiation therapy for rectal cancer: Changes in tumor perfusion and correlation between tissue and radiological markers of response.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32 (pp. 1 page). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY. doi:10.1200/jco.2014.32.3_suppl.491

Astin, R., Jack, S., Loughney, L., Barben, C., Grocott, M., Brown, G., & West, M. A. (2014). Training Response To A Structured Exercise Program Is Associated With Greater Tumour Regression In Rectal Cancer Following Neoadjuvant Chemoradiotherapy. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 189 (pp. 2 pages). AMER THORACIC SOC. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209838206461&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Sondenaa, K., Quirke, P., Hohenberger, W., Sugihara, K., Kobayashi, H., Kessler, H., . . . Moran, B. (2014). The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 29(4), 419-428. doi:10.1007/s00384-013-1818-2

Watkins, D. J., Starling, N., Chau, I., Thomas, J., Webb, J., Oates, J. R., . . . Cunningham, D. (2010). The combination of a chemotherapy doublet (gemcitabine plus capecitabine) with a biologic doublet (bevacizumab plus erlotinib) in patients with advanced pancreatic adenocarcinoma : The TARGET study.. JOURNAL OF CLINICAL ONCOLOGY, 28(15), 1 page. doi:10.1200/jco.2010.28.15_suppl.4036

Sclafani, F., Gonzalez, D., Cunningham, D., Wilson, S. H., Peckitt, C., Giralt, J., . . . Chau, I. (2014). RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial. EUROPEAN JOURNAL OF CANCER, 50(8), 1430-1436. doi:10.1016/j.ejca.2014.02.002

Yu, S. K. T., Chand, M., Tait, D. M., & Brown, G. (2014). Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. EUROPEAN JOURNAL OF CANCER, 50(5), 920-927. doi:10.1016/j.ejca.2013.12.007

Chand, M., Moran, B. J., Jones, R. G., Heald, R. J., & Brown, G. (2014). Lymph Node Status Does Not Predict Local Recurrence in the Total Mesorectal Excision Era. DISEASES OF THE COLON & RECTUM, 57(1), 127-129. doi:10.1097/DCR.0000000000000001

Waage, J., Taylor, F., Read, J., & Brown, G. (2014). Imaging assessment of early rectal cancer.. Recent Results Cancer Res, 203, 3-14. doi:10.1007/978-3-319-08060-4_1

Battersby, N. J., Balyasnikova, S., & Brown, G. (2014). Guiding post-treatment decisions in rectal cancer: mrTRG is a practical place to start.. Oncology (Williston Park, N.Y.), 28(8), 677-680.

Tudyka, V., Blomqvist, L., Beets-Tan, R. G. H., Boelens, P. G., Valentini, V., van de Velde, C. J., . . . Brown, G. (2014). EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: The radiology experts review. EJSO, 40(4), 469-475. doi:10.1016/j.ejso.2013.10.029

Chand, M., Swift, R. I., Chau, I., Heald, R. J., Tekkis, P. P., & Brown, G. (2014). Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 96(7), 543-546. doi:10.1308/003588414X13814021678835

Yu, S. K. T., Bhangu, A., Tait, D. M., Tekkis, P., Wotherspoon, A., & Brown, G. (2014). Chemoradiotherapy response in recurrent rectal cancer. CANCER MEDICINE, 3(1), 111-117. doi:10.1002/cam4.169

Chand, M., Yu, S., Swift, R. I., & Brown, G. (2014). Mucinous carcinoma of the rectum: a distinct clinicopathological entity. TECHNIQUES IN COLOPROCTOLOGY, 18(4), 335-344. doi:10.1007/s10151-013-1099-3

Chand, M., Swift, R. I., Tekkis, P. P., Chau, I., & Brown, G. (2014). Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. BRITISH JOURNAL OF CANCER, 110(1), 19-25. doi:10.1038/bjc.2013.603

Bhangu, A., Kiran, R. P., Slesser, A., Fitzgerald, J. E., Brown, G., & Tekkis, P. (2013). Survival After Resection of Colorectal Cancer Based on Anatomical Segment of Involvement. ANNALS OF SURGICAL ONCOLOGY, 20(13), 4161-4168. doi:10.1245/s10434-013-3104-5

Taylor, F. G. M., Quirke, P., Heald, R. J., Moran, B. J., Blomqvist, L., Swift, I. R., . . . Brown, G. (2014). Preoperative Magnetic Resonance Imaging Assessment of Circumferential Resection Margin Predicts Disease-Free Survival and Local Recurrence: 5-Year Follow-Up Results of the MERCURY Study. JOURNAL OF CLINICAL ONCOLOGY, 32(1), 34-U114. doi:10.1200/JCO.2012.45.3258

How, P., West, N. P., & Brown, G. (2014). An MRI-based Assessment of Standard and Extralevator Abdominoperineal Excision Specimens: Time for a Patient Tailored Approach?. ANNALS OF SURGICAL ONCOLOGY, 21(3), 822-828. doi:10.1245/s10434-013-3378-7

Moran, B. J., Holm, T., Brannagan, G., Chave, H., Quirke, P., West, N., . . . McMeeking, A. (2014). The English National Low Rectal Cancer Development Programme: key messages and future perspectives. COLORECTAL DISEASE, 16(3), 173-178. doi:10.1111/codi.12501

Chand, M., Rasheed, S., Bhangu, A., Stamp, G. W. H., Swift, R. I., Tekkis, P. P., & Brown, G. (2014). Adjuvant chemotherapy improves overall survival after TME surgery in mucinous carcinoma of the rectum. EJSO, 40(2), 240-245. doi:10.1016/j.ejso.2013.11.005

Bhangu, A., Wood, G., Brown, G., Darzi, A., Tekkis, P., & Goldin, R. (2014). The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer. COLORECTAL DISEASE, 16(4), O133-O143. doi:10.1111/codi.12482

2013

Yu, S. K. T., Tait, D., Chau, I., & Brown, G. (2013). MRI Predictive Factors for Tumor Response in Rectal Cancer Following Neoadjuvant Chemoradiation Therapy – Implications for Induction Chemotherapy?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(3), 505-511. doi:10.1016/j.ijrobp.2013.06.2052

van de Velde, C. J. H., Boelens, P. G., Borras, J. M., Coebergh, J. -W., Cervantes, A., Blomqvist, L., . . . Valentini, V. (2014). EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. EUROPEAN JOURNAL OF CANCER, 50(1), 34 pages. doi:10.1016/j.ejca.2013.06.048

Tam, H. H., Collins, D. J., Brown, G., Chau, I., Cunningham, D., Leach, M. O., & Koh, D. -M. (2013). The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis. BRITISH JOURNAL OF RADIOLOGY, 86(1030), 8 pages. doi:10.1259/bjr.20130281

Chand, M., Heald, R. J., & Brown, G. (2013). The importance of not overstaging mesorectal lymph nodes seen on MRI. COLORECTAL DISEASE, 15(10), 1201-1204. doi:10.1111/codi.12435

Bhangu, A., Kiran, R., Patel, P., Brown, G., & Tekkis, P. (2013). Survival after resection of colorectal cancer based on anatomical segment of involvement. BRITISH JOURNAL OF SURGERY, 100, 62. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326083400186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Slesser, A. A. P., Chand, M., Goldin, R., Brown, G., Tekkis, P. P., & Mudan, S. (2013). Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases. EJSO, 39(12), 1384-1393. doi:10.1016/j.ejso.2013.09.012

Sclafani, F., Cunningham, D., Tabernero, J., Glimelius, B., Cervantes, A., Peckitt, C., . . . Chau, I. (2013). Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients. In EUROPEAN JOURNAL OF CANCER Vol. 49 (pp. S487). Amsterdam, NETHERLANDS: ELSEVIER SCI LTD. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843603224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Sclafani, F., Gonzalez, D., Cunningham, D., Wilson, S. H., Peckitt, C., Tabernero, J., . . . Chau, I. (2013). TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial. EUROPEAN JOURNAL OF CANCER, 49, S4. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209470600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Chand, M., & Brown, G. (2013). Pre-operative staging of rectal cancer: MRI or ultrasound?. Seminars in Colon and Rectal Surgery, 24(3), 114-118. doi:10.1053/j.scrs.2013.03.002

van de Velde, C. J. H., Aristei, C., Boelens, P. G., Beets-Tan, R. G. H., Blomqvist, L., Borras, J. M., . . . Valentini, V. (2013). EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe. EUROPEAN JOURNAL OF CANCER, 49(13), 2784-2790. doi:10.1016/j.ejca.2013.04.032

Bhangu, A., Brown, G., Nicholls, R. J., Wong, J., Darzi, A., & Tekkis, P. (2013). Survival Outcome of Local Excision versus Radical Resection of Colon or Rectal Carcinoma A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study. ANNALS OF SURGERY, 258(4), 563-571. doi:10.1097/SLA.0b013e3182a4e85a

Nougaret, S., Reinhold, C., Mikhael, H. W., Rouanet, P., Bibeau, F., & Brown, G. (2013). The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”?. RADIOLOGY, 268(2), 329-343. doi:10.1148/radiol.13121361

Dighe, S., Blake, H., Jeyadevan, N., Castellano, I., Koh, D. -M., Orton, M., . . . Brown, G. (2013). Perfusion CT Vascular Parameters Do Not Correlate with Immunohistochemically Derived Microvessel Density Count in Colorectal Tumors. RADIOLOGY, 268(2), 400-410. doi:10.1148/radiol.13112460

Bott, R., Chand, M., Bhoday, J., Swift, R. I., & Brown, G. (2013). MRI-detected EMVI (Mremvi) should be considered in addition to histopathological EMVI status with regards to treatment decisions in rectal cancer. In BRITISH JOURNAL OF SURGERY Vol. 100 (pp. 130-131). Glasgow, SCOTLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326083400392&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Bhangu, A., Beynon, J., Brown, G., Chang, G., Das, P., Desai, A., . . . Woodhouse, C. (2013). Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. BRITISH JOURNAL OF SURGERY, 100(8), E1-E33. doi:10.1002/bjs.9192

Patel, U. B., & Brown, G. (2013). MRI-based assessment of tumor regression in rectal cancer. Current Colorectal Cancer Reports, 9(2), 136-145. doi:10.1007/s11888-013-0169-2

Bott, R. K., Chand, M., Nash, G. F., Swift, R. I., & Brown, G. (2013). The role of MRI in treatment planning for rectal cancer – a review. Current Cancer Therapy Reviews, 9(2), 111-116. doi:10.2174/1573394711309020003

Costa-Silva, L., & Brown, G. (2013). Magnetic Resonance Imaging of Rectal Cancer. MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 21(2), 385-+. doi:10.1016/j.mric.2013.01.006

Bhangu, A., Fitzgerald, E., Brown, G., & Tekkis, P. (2012). Indications and outcomes of abdominosacral resection for locally advanced primary and recurrent rectal cancer. BRITISH JOURNAL OF SURGERY, 99, 106-107. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306123100325&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Slesser, A. A. P., Simillis, C., Goldin, R., Brown, G., Mudan, S., & Tekkis, P. P. (2013). A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. SURGICAL ONCOLOGY-OXFORD, 22(1), 36-47. doi:10.1016/j.suronc.2012.11.002

Bhangu, A., Ali, S. M., Cunningham, D., Brown, G., & Tekkis, P. (2013). Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. COLORECTAL DISEASE, 15(2), 156-163. doi:10.1111/j.1463-1318.2012.03123.x

Slesser, A. A. P., Georgiou, P., Brown, G., Mudan, S., Goldin, R., & Tekkis, P. (2013). The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review. CLINICAL & EXPERIMENTAL METASTASIS, 30(4), 457-470. doi:10.1007/s10585-012-9551-8

Morton, U. K. D., Seymour, M., Magill, L., Handley, K., Brown, G., Ferry, D., . . . Gray, R. (2012). Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. LANCET ONCOLOGY, 13(11), 1152-1160. doi:10.1016/S1470-2045(12)70348-0

Dighe, S., Castellano, E., Blake, H., Jeyadevan, N., Koh, M. U., Orten, M., . . . Brown, G. (2012). Perfusion CT to assess angiogenesis in colon cancer: technical limitations and practical challenges. BRITISH JOURNAL OF RADIOLOGY, 85(1018), E814-E825. doi:10.1259/bjr/19855447

Bhangu, A., Brown, G., Akmal, M., & Tekkis, P. (2012). Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer. BRITISH JOURNAL OF SURGERY, 99(10), 1453-1461. doi:10.1002/bjs.8881

Patel, U. B., Blomqvist, L. K., Taylor, F., George, C., Guthrie, A., Bees, N., & Brown, G. (2012). MRI After Treatment of Locally Advanced Rectal Cancer: How to Report Tumor Response-The MERCURY Experience. AMERICAN JOURNAL OF ROENTGENOLOGY, 199(4), W486-W495. doi:10.2214/AJR.11.8210

Chand, M., Bhoday, J., Brown, G., Moran, B., & Parvaiz, A. (2012). Laparoscopic surgery for rectal cancer. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 105(10), 429-435. doi:10.1258/jrsm.2012.120070

Georgiou, P. A., Tekkis, P. P., Constantinides, V. A., Patel, U., Goldin, R. D., Darzi, A. W., . . . Brown, G. (2013). Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. EUROPEAN JOURNAL OF CANCER, 49(1), 72-81. doi:10.1016/j.ejca.2012.06.025

Slesser, A. A. P., Bhangu, A., Brown, G., Mudan, S., & Tekkis, P. P. (2013). The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma. TECHNIQUES IN COLOPROCTOLOGY, 17(1), 1-12. doi:10.1007/s10151-012-0888-4

2012

Hunter, C., Brown, G., Temple, L., Abulafi, M., & Arnaout, A. (2012). Magnetic resonance imaging assisted tumour block selection in colorectal cancer. VIRCHOWS ARCHIV, 461, S179. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310364801512&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Patel, U. B., Brown, G., Rutten, H., West, N., Sebag-Montefiore, D., Glynne-Jones, R., . . . Quirke, P. (2012). Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal Cancer. ANNALS OF SURGICAL ONCOLOGY, 19(9), 2842-2852. doi:10.1245/s10434-012-2309-3

Shihab, O. C., Heald, R. J., Holm, T., How, P. D., Brown, G., Quirke, P., & Moran, B. J. (2012). A pictorial description of extralevator abdominoperineal excision for low rectal cancer. COLORECTAL DISEASE, 14(10), E655-E660. doi:10.1111/j.1463-1318.2012.03181.x

Al-Sukhni, E., Milot, L., Fruitman, M., Beyene, J., Victor, J. C., Schmocker, S., . . . Kennedy, E. (2012). Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. ANNALS OF SURGICAL ONCOLOGY, 19(7), 2212-2223. doi:10.1245/s10434-011-2210-5

How, P., Evans, J., Moran, B., Swift, I., & Brown, G. (2012). Preoperative MRI sphincter morphology and anal manometry: can they be markers of functional outcome following anterior resection for rectal cancer?. COLORECTAL DISEASE, 14(6), E339-E345. doi:10.1111/j.1463-1318.2012.02942.x

Dewdney, A., Chau, I., Capdevila, J., Glimelius, B., Cervantes-Ruiperez, A., Tait, D. M., . . . Cunningham, D. (2012). The impact of TP53 mutation on high-risk rectal cancer patients treated within the EXPERT-C trial, a randomized phase II study of neoadjuvant oxaliplatin/capecitabine (CAPOX) and chemoradiation (CRT) with or without cetuximab.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 30 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009804716&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Fernandez-Martos, C., Estevan, R., Salud, A., Pericay, C., Gallen, M., Sierra, E., . . . Brown, G. (2012). Neoadjuvant capecitabine, oxliplatin, and bevacizumab (CAPOX-B) in intermediate-risk rectal cancer (RC) patients defined by magnetic resonance (MR): GEMCAD 0801 trial.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 30 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803825&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G., Bharat Patel, U., Santos Cores, J., Gil Garcia, M. I., Ramon Ayuso, J., Puchades Roman, I., . . . Fernandez-Martos, C. (2012). Comparison of magnetic resonance imaging and histopathological response to neoadjuvant chemotherapy in locally advanced rectal cancer: The GEMCAD 0801 trial.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 30 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802738&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Bhangu, A., Ali, M., Cunningham, D., Brown, G., & Tekkis, P. P. (2012). Comparison of long-term survival outcomes of operative versus nonoperative management of recurrent rectal cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 30 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009800867&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Dewdney, A., Cunningham, D., Tabernero, J., Capdevila, J., Glimelius, B., Cervantes, A., . . . Chau, I. (2012). Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C). JOURNAL OF CLINICAL ONCOLOGY, 30(14), 1620-1627. doi:10.1200/JCO.2011.39.6036

Dighe, S., Swift, I., Magill, L., Handley, K., Gray, R., Quirke, P., . . . Brown, G. (2012). Accuracy of radiological staging in identifying high-risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience. COLORECTAL DISEASE, 14(4), 438-444. doi:10.1111/j.1463-1318.2011.02638.x

Starling, N., Hawkes, E. A., Chau, I., Watkins, D., Thomas, J., Webb, J., . . . Cunningham, D. (2012). A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma. ANNALS OF ONCOLOGY, 23(4), 942-947. doi:10.1093/annonc/mdr317

Brown, G., Evans, J., Tait, D., Swift, I., Tekkis, P., Wotherspoon, A., & Chau, I. (2012). Timing of Surgery Following Preoperative Therapy in Rectal Cancer: There Is No Need for a Prospective Randomized Trial Reply. DISEASES OF THE COLON & RECTUM, 55(3), E31-E32. doi:10.1097/DCR.0b013e31823f86dd

West, N., Hemmings, G. J., Richman, S. D., Taylor, M., Chambers, P., Magill, L., . . . Quirke, P. (2012). KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial. In JOURNAL OF PATHOLOGY Vol. 226 (pp. S4). Dept Cellular Pathol, London, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000300669800010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

West, N., Tinkler-Hundal, E., Handley, K., Magill, L., Lancaster, D., Seymour, M., . . . Quirke, P. (2012). Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial. In JOURNAL OF PATHOLOGY Vol. 226 (pp. S23). Dept Cellular Pathol, London, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000300669800083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Bhangu, A., Ali, S. M., Darzi, A., Brown, G., & Tekkis, P. (2012). Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. COLORECTAL DISEASE, 14(12), 1457-1466. doi:10.1111/j.1463-1318.2012.03005.x

Yu, S. K., Brown, G., & Tait, D. M. (2012). Use of MRI-defined tumor distance from the anal verge to predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.. J Clin Oncol, 30(4_suppl), 573. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27983202

Currie, A. C., Evans, J., Smith, N. J., Brown, G., Abulafi, A. M., & Swift, R. I. (2012). The impact of the two-week wait referral pathway on rectal cancer survival. COLORECTAL DISEASE, 14(7), 848-853. doi:10.1111/j.1463-1318.2011.02829.x

Brown, G. (2012). Specialist multidisciplinary team working in the treatment of cancer Improves survival, possibly through enabling bolder treatment. BMJ-BRITISH MEDICAL JOURNAL, 344, 2 pages. doi:10.1136/bmj.e2780

Tam, H. H., Collins, D. J., Wallace, T., Brown, G., Riddell, A., & Koh, D. -M. (2012). Segmental liver hyperintensity in malignant biliary obstruction on diffusion weighted MRI: associated MRI findings and relationship with serum alanine aminotransferase levels. BRITISH JOURNAL OF RADIOLOGY, 85(1009), 22-28. doi:10.1259/bjr/24852804

Bhangu, A., Slesser, A., Brown, G., & Tekkis, P. (2012). Indications and outcomes of pelvic exenteration for locally advanced primary and recurrent rectal cancer. In BRITISH JOURNAL OF SURGERY Vol. 99 (pp. 70-71). Liverpool, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306123100208&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Bhangu, A., Ali, M., Cunningham, D., Brown, G., & Tekkis, P. (2012). Comparison of long-term survival outcomes of operative versus non-operative management of recurrent rectal cancer. In BRITISH JOURNAL OF SURGERY Vol. 99 (pp. 95). Liverpool, ENGLAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306123100284&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

2011

Hunter, C. J., Garant, A., Vuong, T., Artho, G., Lisbona, R., Tekkis, P., . . . Brown, G. (2012). Adverse Features on Rectal MRI Identify a High-risk Group that May Benefit from More Intensive Preoperative Staging and Treatment. ANNALS OF SURGICAL ONCOLOGY, 19(4), 1199-1205. doi:10.1245/s10434-011-2036-1

Pedersen, B. G., Moran, B., Brown, G., Blomqvist, L., Fenger-Gron, M., & Laurberg, S. (2011). Reproducibility of Depth of Extramural Tumor Spread and Distance to Circumferential Resection Margin at Rectal MRI: Enhancement of Clinical Guidelines for Neoadjuvant Therapy. AMERICAN JOURNAL OF ROENTGENOLOGY, 197(6), 1360-1366. doi:10.2214/AJR.11.6508

Shihab, O. C., Taylor, F., Bees, N., Blake, H., Jeyadevan, N., Bleehen, R., . . . Brown, G. (2011). Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. BRITISH JOURNAL OF SURGERY, 98(12), 1798-1804. doi:10.1002/bjs.7662

Shihab, O. C., Taylor, F., Salerno, G., Heald, R. J., Quirke, P., Moran, B. J., & Brown, G. (2011). MRI Predictive Factors for Long-Term Outcomes of Low Rectal Tumours. ANNALS OF SURGICAL ONCOLOGY, 18(12), 3278-3284. doi:10.1245/s10434-011-1776-2

Chand, M., & Brown, G. (2012). What are the relevant imaging factors to optimize treatment decisions?. In Multidisciplinary Management of Rectal Cancer: Questions and Answers (Vol. 9783642250057, pp. 27-39). doi:10.1007/978-3-642-25005-7_4

Evans, J., Tait, D., Swift, I., Pennert, K., Tekkis, P., Wotherspoon, A., . . . Brown, G. (2011). Timing of Surgery Following Preoperative Therapy in Rectal Cancer: The Need for a Prospective Randomized Trial?. DISEASES OF THE COLON & RECTUM, 54(10), 1251-1259. doi:10.1097/DCR.0b013e3182281f4b

Chua, S., Georgiou, P., Brown, G., Cook, G., Drake, B., Antoniou, A., & Tekkis, P. (2011). The added value of combined 18F-FDG PET-MRI in the preoperative assessment of local tumour invasion in recurrent and locally advanced primary rectal cancer using pelvic compartmental analysis. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 38, S194. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208619400368&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Chand, M., & Brown, G. (2012). How can we identify tumour penetration?. In Multidisciplinary Management of Rectal Cancer: Questions and Answers (Vol. 9783642250057, pp. 59-65). doi:10.1007/978-3-642-25005-7_7

Shihab, O. C., How, P., West, N., George, C., Patel, U., Quirke, P., . . . Brown, G. (2011). Can a Novel MRI Staging System for Low Rectal Cancer Aid Surgical Planning?. DISEASES OF THE COLON & RECTUM, 54(10), 1260-1264. doi:10.1097/DCR.0b013e31822abd78

Chua, S., Yu, S., Drake, B., Patel, U., Tait, D., Cook, G., . . . Brown, G. (2011). A prospective multicentre study to evaluate the diagnostic ability of multimodality imaging (FDG PET/CT, MRI and DW-MRI) in detecting early rectal tumour regrowth in cases of deferral of rectal surgery following continued response to preoperative chemoradiotherapy(CRT). EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 38, S157. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208619400236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G. (2011). Commentary: MRI should not predict histopathological involved margins. COLORECTAL DISEASE, 13(9), 982-983. doi:10.1111/j.1463-1318.2011.02717.x

Wong, R., Cunningham, D., Barbachano, Y., Saffery, C., Valle, J., Hickish, T., . . . Chau, I. (2011). A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. ANNALS OF ONCOLOGY, 22(9), 2042-2048. doi:10.1093/annonc/mdq714

Patel, U. B., Taylor, F., Blomqvist, L., George, C., Evans, H., Tekkis, P., . . . Brown, G. (2011). Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. JOURNAL OF CLINICAL ONCOLOGY, 29(28), 3753-3760. doi:10.1200/JCO.2011.34.9068

Evans, J., Patel, U., & Brown, G. (2011). Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy. SEMINARS IN RADIATION ONCOLOGY, 21(3), 169-177. doi:10.1016/j.semradonc.2011.02.002

Hawkes, E. A., Cunningham, D., Tait, D., Brown, G., & Chau, I. (2011). Neoadjuvant Chemotherapy Alone for Early-Stage Rectal Cancer: An Evolving Paradigm?. SEMINARS IN RADIATION ONCOLOGY, 21(3), 196-202. doi:10.1016/j.semradonc.2011.02.005

Glimelius, B., Beets-Tan, R., Blomqvist, L., Brown, G., Nagtegaal, I., Pahlman, L., . . . van de Velde, C. (2011). Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(16), 2142-2143. doi:10.1200/JCO.2010.34.4473

How, P., Shihab, O., Tekkis, P., Brown, G., Quirke, P., Heald, R., & Moran, B. (2011). A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. SURGICAL ONCOLOGY-OXFORD, 20(4), E149-E155. doi:10.1016/j.suronc.2011.05.001

Morton, D., Magill, L., Handley, K., Brown, G., Ferry, D. R., Gray, Z. B., . . . FOxTROT Collaborative Group. (2011). FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report.. J Clin Oncol, 29(15_suppl), 3568. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28020286

Morton, D., Magill, L., Handley, K., Brown, G., Ferry, D. R., Gray, Z. B., . . . Gray, R. G. (2011). FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report. JOURNAL OF CLINICAL ONCOLOGY, 29(15), 1 page. doi:10.1200/jco.2011.29.15_suppl.3568

Dewdney, A., Capdevila, J., Glimelius, B., Cervantes, A., Tait, D. M., Brown, G., . . . Cunningham, D. (2011). EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer.. J Clin Oncol, 29(15_suppl), 3513. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28020332

Dewdney, A., Capdevila, J., Glimelius, B., Cervantes, A., Tait, D. M., Brown, G., . . . Cunningham, D. (2011). EXPERT-C: A randomized, phase II European multicenter trial of neoadjuvant capecitabine plus oxaliplatin chemotherapy (CAPOX) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined, high-risk rectal cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(15), 1 page. doi:10.1200/jco.2011.29.15_suppl.3513

Taylor, F. G. M., Quirke, P., Heald, R. J., Moran, B., Blomqvist, L., Swift, I., . . . Brown, G. (2011). One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. BRITISH JOURNAL OF SURGERY, 98(6), 872-879. doi:10.1002/bjs.7458

Taylor, F. G. M., Quirke, P., Heald, R. J., Moran, B., Blomqvist, L., Swift, I., . . . MERCURY study group. (2011). Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study.. Ann Surg, 253(4), 711-719. doi:10.1097/SLA.0b013e31820b8d52

Hunter, C., Garant, A., Vuong, T., Artho, G., Lisbona, R., Abulafi, M., & Brown, G. (2011). Potential therapeutic impact of routine pre-operative staging with FDG-PET/CT in high and low risk rectal cancer. In BRITISH JOURNAL OF SURGERY Vol. 98 (pp. 36). Royal Coll Surgery, Dublin, IRELAND: WILEY-BLACKWELL. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290664500120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Pedersen, B. G., Blomqvist, L., Brown, G., Fenger-Gron, M., Moran, B., & Laurberg, S. (2011). Postgraduate Multidisciplinary Development Program: Impact on the Interpretation of Pelvic MRI in Patients With Rectal Cancer: A Clinical Audit in West Denmark. DISEASES OF THE COLON & RECTUM, 54(3), 328-334. doi:10.1007/DCR.0b013e3182031e83

Georgiou, P. A., Tekkis, P. P., Patel, U., Antoniou, A., Darzi, A. W., Cunningham, D., . . . Brown, G. (2011). The added value of diffusion-weighted magnetic resonance imaging (DW-MRI) in the local staging of advanced colorectal pelvic cancer.. J Clin Oncol, 29(4_suppl), 378. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27985528

Georgiou, P. A., Tekkis, P. P., Patel, U., Antoniou, A., Darzi, A. W., Cunningham, D., . . . Brown, G. (2011). The added value of diffusion-weighted magnetic resonance imaging (DW-MRI) in the local staging of advanced colorectal pelvic cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(4), 1 page. doi:10.1200/jco.2011.29.4_suppl.378

Hunter, C. J., Scurr, E., Jeyadevan, N., Collins, D. J., Abulafi, M., Tekkis, P. P., . . . Brown, G. (2011). Optimising magnetic resonance imaging for preoperative staging and surgical planning in colon cancer at 1.5 tesla and 3.0 tesla.. J Clin Oncol, 29(4_suppl), 395. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27985624

Hunter, C. J., Scurr, E., Jeyadevan, N., Collins, D. J., Abulafi, M., Tekkis, P. P., . . . Brown, G. (2011). Optimising magnetic resonance imaging for preoperative staging and surgical planning in colon cancer at 1.5 tesla and 3.0 tesla. JOURNAL OF CLINICAL ONCOLOGY, 29(4), 1 page. doi:10.1200/jco.2011.29.4_suppl.395

Dewdney, A., Cunningham, D., Tabernero, J., Glimelius, B., Cervantes, A., Tait, D. M., . . . Chau, I. (2011). EXPERT-C: A randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer.. J Clin Oncol, 29(4_suppl), 360. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27985488

Dewdney, A., Cunningham, D., Tabernero, J., Glimelius, B., Cervantes, A., Tait, D. M., . . . Chau, I. (2011). EXPERT-C: A randomized phase II European multicenter trial of neoadjuvant chemotherapy (capecitabine/oxaliplatin) and chemoradiation (CRT) with or without cetuximab followed by total mesorectal excision (TME) in patients with MRI-defined high-risk rectal cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(4), 1 page. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208847100358&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Tekkis, P. P., Georgiou, P. A., Constantinides, V. A., Patel, U., Antoniou, A., Goldin, R. D., . . . Brown, G. (2011). Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal pelvic cancer.. J Clin Oncol, 29(4_suppl), 370. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27985511

Tekkis, P. P., Georgiou, P. A., Constantinides, V. A., Patel, U., Antoniou, A., Goldin, R. D., . . . Brown, G. (2011). Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal pelvic cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(4), 1 page. doi:10.1200/jco.2011.29.4_suppl.370

Yu, S. K., Brown, G., Heald, R. J., Chua, S., Cook, G., Barbachano, Y., . . . Tait, D. M. (2011). Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: A phase II multicenter study in the United Kingdom.. J Clin Oncol, 29(4_suppl), 489. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27985501

Taylor, F. G. M., Quirke, P., Heald, R. J., Moran, B., Blomqvist, L., Swift, I., . . . Brown, G. (2011). Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery Alone A Prospective, Multicenter, European Study. ANNALS OF SURGERY, 253(4), 711-719. doi:10.1097/SLA.0b013e31820b8d52

Georgiou, P. A., Tekkis, P. P., & Brown, G. (2011). Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.. Cancer Imaging, 11 Spec No A, S103-S111. doi:10.1102/1470-7330.2011.9025

2010

Shihab, O. C., Quirke, P., Heald, R. J., Moran, B. J., & Brown, G. (2010). Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. BRITISH JOURNAL OF SURGERY, 97(9), 1431-1436. doi:10.1002/bjs.7116

Dighe, S., Purkayastha, S., Swift, I., Tekkis, P. P., Darzi, A., A’Hern, R., & Brown, G. (2010). Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. CLINICAL RADIOLOGY, 65(9), 708-719. doi:10.1016/j.crad.2010.01.024

Dighe, S., Blake, H., Koh, M. -D., Swift, I., Arnaout, A., Temple, L., . . . Brown, G. (2010). Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer. BRITISH JOURNAL OF SURGERY, 97(9), 1407-1415. doi:10.1002/bjs.7096

Koh, D. -M., George, C., Temple, L., Collins, D. J., Toomey, P., Raja, A., . . . Brown, G. (2010). Diagnostic Accuracy of Nodal Enhancement Pattern of Rectal Cancer at MRI Enhanced With Ultrasmall Superparamagnetic Iron Oxide: Findings in Pathologically Matched Mesorectal Lymph Nodes. AMERICAN JOURNAL OF ROENTGENOLOGY, 194(6), W505-W513. doi:10.2214/AJR.08.1819

Fernandez-Martos, C., Safont, M., Feliu, J., Pericay, C., Gallen, M., Vera, R., . . . Brown, G. (2010). Induction chemotherapy with or without chemoradiation in intermediate-risk rectal cancer patients defined by magnetic resonance imaging (MRI): A GEMCAD study. JOURNAL OF CLINICAL ONCOLOGY, 28(15), 1 page. doi:10.1200/jco.2010.28.15_suppl.tps196

Gray, R. G., Morton, D., Brown, G., Ferry, D. R., Magill, L., Quirke, P., . . . Warren, B. (2010). FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer. JOURNAL OF CLINICAL ONCOLOGY, 28(15), 1 page. doi:10.1200/jco.2010.28.15_suppl.tps192

Chua, Y. J., Barbachano, Y., Cunningham, D., Oates, J. R., Brown, G., Wotherspoon, A., . . . Chau, I. (2010). Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. LANCET ONCOLOGY, 11(3), 241-248. doi:10.1016/S1470-2045(09)70381-X

Georgiou, P., Tan, E., Gouvas, N., Antoniou, A., Brown, G., nicholls, R. J., & Tekkis, P. (2010). Lateral pelvic lymph-node dissection: still an option for cure Reply. LANCET ONCOLOGY, 11(2), 114-115. doi:10.1016/S1470-2045(10)70015-2

Watkins, D. J., Chau, I., Cunningham, D., Mudan, S. S., Karanjia, N., Brown, G., . . . Gillbanks, A. (2010). Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. BRITISH JOURNAL OF CANCER, 102(2), 255-261. doi:10.1038/sj.bjc.6605508

Taylor, F., Mangat, N., Swift, I. R., & Brown, G. (2010). Proforma-based reporting in rectal cancer.. Cancer Imaging, 10 Spec no A, S142-S150. doi:10.1102/1470-7330.2010.9092

Shihab, O. C., Brown, G., Daniels, I. R., Heald, R. J., Quirke, P., & Moran, B. J. (2010). Patients With Low Rectal Cancer Treated by Abdominoperineal Excision Have Worse Tumors and Higher Involved Margin Rates Compared With Patients Treated by Anterior Resection. DISEASES OF THE COLON & RECTUM, 53(1), 53-56. doi:10.1007/DCR.0b013e3181c70465

2009

Shihab, O. C., Heald, R. J., Rullier, E., Brown, G., Holm, T., Quirke, P., & Moran, B. J. (2009). Defining the surgical planes on MRI improves surgery for cancer of the low rectum. LANCET ONCOLOGY, 10(12), 1207-1211. doi:10.1016/S1470-2045(09)70084-1

Starling, N., Watkins, D., Cunningham, D., Thomas, J., Webb, J., Brown, G., . . . Chau, I. (2009). Dose Finding and Early Efficacy Study of Gemcitabine Plus Capecitabine in Combination With Bevacizumab Plus Erlotinib in Advanced Pancreatic Cancer. JOURNAL OF CLINICAL ONCOLOGY, 27(33), 5499-5505. doi:10.1200/JCO.2008.21.5384

Georgiou, P., Tan, E., Gouvas, N., Antoniou, A., Brown, G., Nicholls, R. J., & Tekkis, P. (2009). Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. LANCET ONCOLOGY, 10(11), 1053-1062. doi:10.1016/S1470-2045(09)70224-4

Leary, A., Assersohn, L., Cunningham, D., Norman, A. R., Chong, G., Brown, G., . . . Oates, J. (2009). A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 64(3), 455-462. doi:10.1007/s00280-008-0893-5

O’Neill, B. D. P., Salerno, G., Thomas, K., Tait, D. M., & Brown, G. (2009). MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. BRITISH JOURNAL OF RADIOLOGY, 82(978), 509-513. doi:10.1259/bjr/60198873

Starling, N., Okines, A., Cunningham, D., Allum, W., Wotherspoon, A., Benson, M., . . . Chau, I. (2009). A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma. BRITISH JOURNAL OF CANCER, 100(11), 1725-1730. doi:10.1038/sj.bjc.6605070

Salerno, G. V., Daniels, I. R., Moran, B. J., Heald, R. J., Thomas, K., & Brown, G. (2009). Magnetic Resonance Imaging Prediction of an Involved Surgical Resection Margin in Low Rectal Cancer. DISEASES OF THE COLON & RECTUM, 52(4), 632-639. doi:10.1007/DCR.0b013e3181a0a37e

Shihab, O. C., Moran, B. J., Heald, R. J., Quirke, P., & Brown, G. (2009). MRI staging of low rectal cancer. EUROPEAN RADIOLOGY, 19(3), 643-650. doi:10.1007/s00330-008-1184-6

Potter, K. C., Husband, J. E., Houghton, S. L., Thomas, K., & Brown, G. (2009). Diagnostic Accuracy of Serial CT/Magnetic Resonance Imaging Review vs. Positron Emission Tomography/CT in Colorectal Cancer Patients with Suspected and Known Recurrence. DISEASES OF THE COLON & RECTUM, 52(2), 253-259. doi:10.1007/DCR.0b013e31819d11e6

Koh, D. -M., Brown, G., & Collins, D. J. (2009). Nanoparticles in rectal cancer imaging. CANCER BIOMARKERS, 5(2), 89-98. doi:10.3233/CBM-2009-0544

2008

Dighe, S., Swift, I., & Brown, G. (2008). CT staging of colon cancer. CLINICAL RADIOLOGY, 63(12), 1372-1379. doi:10.1016/j.crad.2008.04.021

Taylor, F. G. M., Swift, R. I., Blomqvist, L., & Brown, G. (2008). A Systematic Approach to the Interpretation of Preoperative Staging MRI for Rectal Cancer. AMERICAN JOURNAL OF ROENTGENOLOGY, 191(6), 1827-1835. doi:10.2214/AJR.08.1004

Smith, N. J., Shihab, O., Arnaout, A., Swift, R. I., & Brown, G. (2008). MRI for Detection of Extramural Vascular Invasion in Rectal Cancer. AMERICAN JOURNAL OF ROENTGENOLOGY, 191(5), 1517-1522. doi:10.2214/AJR.08.1298

Salerno, G., Chandler, I., Wotherspoon, A., Thomas, K., Moran, B., & Brown, G. (2008). Sites of surgical waisting in the abdominoperineal specimen. BRITISH JOURNAL OF SURGERY, 95(9), 1147-1154. doi:10.1002/bjs.6231

Brown, G. (2008). MRI: STAGING AND RE-STAGING AFTER PREOPERATIVE TREATMENT, NEW CONTRAST AGENTS. In RADIOTHERAPY AND ONCOLOGY Vol. 88 (pp. S128). ELSEVIER IRELAND LTD. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433281200354&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

ONeill, B., Tait, D., & Brown, G. (2008). ANASTOMOTIC LOCAL RECURRENCE OF RECTAL CANCER REMAINS AN IMPORTANT AND PREVENTABLE PATTERN OF FAILURE FOLLOWING TOTAL MESORECTAL EXCISION: LESSONS FOR RADIOTHERAPISTS. In RADIOTHERAPY AND ONCOLOGY Vol. 88 (pp. S87). ELSEVIER IRELAND LTD. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433281200248&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Kong, G., Jackson, C., Koh, D. M., Lewington, V., Sharma, B., Brown, G., . . . Cook, G. J. R. (2008). The use of F-18-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 35(7), 1323-1329. doi:10.1007/s00259-008-0743-z

Koh, D. -M., Chau, I., Tait, D., Wotherspoon, A., Cunningham, D., & Brown, G. (2008). Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 71(2), 456-461. doi:10.1016/j.ijrobp.2007.10.016

Koh, D. M., Brown, G., Riddell, A. M., Scurr, E., Collins, D. J., Allen, S. D., . . . Husband, J. E. (2008). Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. EUROPEAN RADIOLOGY, 18(5), 903-910. doi:10.1007/s00330-007-0847-z

Moran, B., Brown, G., Cunningham, D., Daniels, I., Heald, R., Quirke, P., & Sebag-Montefiore, D. (2008). Clarifying the TNM staging of rectal cancer in the context of modern imaging and neo-adjuvant treatment: ‘y”u’ and ‘p’ need ‘mr’ and ‘ct’. COLORECTAL DISEASE, 10(3), 242-243. doi:10.1111/j.1463-1318.2007.01260.x

Smith, N. J., Barbachano, Y., Norman, A. R., Swift, R. I., Abulafi, A. M., & Brown, G. (2008). Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. BRITISH JOURNAL OF SURGERY, 95(2), 229-236. doi:10.1002/bjs.5917

Koh, D. M., Dzik-Jurasz, A., O’Neill, B., Tait, D., Husband, J. E., & Brown, G. (2008). Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. BRITISH JOURNAL OF RADIOLOGY, 81(962), 91-98. doi:10.1259/bjr/96187638

Park, S. H. (2008). Degree of error of thin-section MR in measuring extramural depth of tumor invasion in patients with rectal cancer.. Radiology, 246(2), 647. doi:10.1148/radiol.2462070843

Brown, G., & Norman, A. R. (2008). Degree of error of thin-section MR in measuring extramural depth of tumor invasion in patients with rectal cancer – Response. RADIOLOGY, 246(2), 648. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252796300049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Koh, D. -M., Smith, N. J., Swift, R. I., & Brown, G. (2008). The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer.. Clin Med Oncol, 2, 267-273. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21892288

O’Neill, B., Brown, G., Wotherspoon, A., Burton, S., Norman, A., & Tait, D. (2008). Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy.. Clin Med Oncol, 2, 135-144. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21892276

Brown, G. (2008). Staging rectal cancer: endoscopic ultrasound and pelvic MRI.. Cancer Imaging, 8 Spec No A, S43-S45. doi:10.1102/1470-7330.2008.9008

Smith, N., & Brown, G. (2008). Preoperative staging of rectal cancer. ACTA ONCOLOGICA, 47(1), 20-31. doi:10.1080/02841860701697720

O’Neill, B. D. P., Tait, D. M., & Brown, G. (2008). Anastomotic local recurrence of rectal cancer remains an important and preventable pattern of failure following total mesorectal excision: Lessons for radiotherapists. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Vol. 72 (pp. S246). Boston, MA: ELSEVIER SCIENCE INC. doi:10.1016/j.ijrobp.2008.06.635

Burton, S., Brown, G., Bees, N., Norman, A., Biedrzycki, O., Arnaout, A., . . . Swift, R. I. (2008). Accuracy of CT prediction of poor prognostic features in colonic cancer. BRITISH JOURNAL OF RADIOLOGY, 81(961), 10-19. doi:10.1259/bjr/19492531

2007

O’Neill, B. D. P., Brown, G., Cunningham, D., Heald, R. J., & Tait, D. M. (2007). Chemoradiotherapy alone for rectal cancer: A word of caution – Reply. LANCET ONCOLOGY, 8(10), 862-863. doi:10.1016/S1470-2045(07)70293-0

O’Neill, B., Chaldecott, R., Brown, G., Sharma, R. A., Norman, A., Scurr, E., . . . Tait, D. M. (2007). Optimisation of radiotherapy planning for rectal cancer: a comparison of supine CT and MRI defined target and normal tissue dose volume data. In EJC SUPPLEMENTS Vol. 5 (pp. 258). Barcelona, SPAIN: PERGAMON-ELSEVIER SCIENCE LTD. doi:10.1016/S1359-6349(07)71001-7

Brown, G. (2007). Imaging of liver metastases (CT scan, MRI, PET scan). EJC SUPPLEMENTS, 5(5), 297-300. doi:10.1016/S1359-6349(07)70056-3

O’Neill, B. D. P., Brown, G., Heald, R. J., Cunningham, D., & Tait, D. M. (2007). Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. LANCET ONCOLOGY, 8(7), 625-633. doi:10.1016/S1470-2045(07)70202-4

Watkins, D. J., Jackson, C., Chua, Y., Chong, G., Norman, A. R., Brown, G., . . . Cunningham, D. (2007). A prospective study of oxaliplatin and capecitabine (CapOx) in metastatic colorectal cancer (MCRC) with baseline stratification according to resectability status. In JOURNAL OF CLINICAL ONCOLOGY Vol. 25 (pp. 2 pages). AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043700678&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Salerno, G., Daniels, I. R., Brown, G., Norman, A. R., Moran, B. J., & Heald, R. J. (2007). Variations in pelvic dimensions do not predict the risk of circumferential resection margin (CRM) involvement in rectal cancer. WORLD JOURNAL OF SURGERY, 31(6), 1313-1320. doi:10.1007/s00268-007-9007-5

Smith, N. J., Bees, N., Barbachano, Y., Norman, A. R., Swift, R. I., & Brown, G. (2007). Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials. BRITISH JOURNAL OF CANCER, 96(7), 1030-1036. doi:10.1038/sj.bjc.6603646

Fowler, J. M., Beagley, C. E., Blomqvist, L., Brown, G., Daniels, I. R., Heald, R. J., . . . Sebag-Montefiore, D. (2007). Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY Study. RADIOLOGY, 243(1), 132-139. doi:10.1148/radiol.2431051825

Riddell, A. M., Allum, W. H., Thompson, J. N., Wotherspoon, A. C., Richardson, C., & Brown, G. (2007). The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. EUROPEAN RADIOLOGY, 17(2), 391-399. doi:10.1007/s00330-006-0363-6

Koh, D. -M., Brown, G., Meer, Z., Norman, A. R., & Husband, J. E. (2007). Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. AMERICAN JOURNAL OF ROENTGENOLOGY, 188(2), W154-W161. doi:10.2214/AJR.05.1421

Starling, N., & Brown, G. (2007). Patterns of recurrence following therapy for rectal cancer. In Colorectal Cancer (pp. 233-247). doi:10.1017/CBO9780511902468.013

Burton, S., & Brown, G. (2007). MRI staging. In Colorectal Cancer (pp. 174-211). doi:10.1017/CBO9780511902468.011

Brown, G. (2007). Imaging of metastatic disease. In Colorectal Cancer (pp. 212-232). doi:10.1017/CBO9780511902468.012

Riddell, A. M., Davies, D. C., Allum, W. H., Wotherspoon, A. C., Richardson, C., & Brown, G. (2007). High-resolution MRI in evaluation of the surgical anatomy of the esophagus and posterior mediastinum. AMERICAN JOURNAL OF ROENTGENOLOGY, 188(1), W37-W43. doi:10.2214/AJR.05.1795

Burton, S., & Brown, G. (2007). CT staging. In Colorectal Cancer (pp. 157-173). doi:10.1017/CBO9780511902468.010

Brown, G., Reznek, R. H., & Husband, J. E. (2007). Colorectal cancer. doi:10.1017/CBO9780511902468

2006

Petroudi, S., Brown, G., Bond, S., & Brady, M. (2006). Circumferential resection margin assessment on MRI of rectal cancer.. Conference proceedings : … Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, 4881-4884.

Riddell, A. M., Richardson, C., Scurr, E., & Brown, G. (2006). The development and optimization of high spatial resolution Mill for imaging the oesophagus using an external surface coil. BRITISH JOURNAL OF RADIOLOGY, 79(947), 873-879. doi:10.1259/bjr/36989440

Riddell, A. M., Hillier, J., Brown, G., King, D. M., Wotherspoon, A. C., Thompson, J. N., . . . Allum, W. H. (2006). Potential of surface-coil MRI for staging of esophageal cancer. AMERICAN JOURNAL OF ROENTGENOLOGY, 187(5), 1280-1287. doi:10.2214/AJR.05.0559

Koh, D. M., Brown, G., & Husband, J. E. (2006). Nodal staging in rectal cancer. ABDOMINAL IMAGING, 31(6), 652-659. doi:10.1007/s00261-006-9021-3

Salerno, G., Daniels, I. R., Brown, G., Heald, R. J., & Moran, B. J. (2006). Magnetic resonance imaging pelvimetry in 186 patients with rectal cancer confirms an overlap in pelvic size between males and females. COLORECTAL DISEASE, 8(9), 772-776. doi:10.1111/j.1463-1318.2006.01090.x

Salerno, G., Daniels, I. R., Moran, B. J., Wotherspoon, A., & Brown, G. (2006). Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience. CLINICAL RADIOLOGY, 61(11), 916-923. doi:10.1016/j.crad.2006.06.005

Heald, R. J., O’Neill, B. D. P., Moran, B., Brown, G., Darzi, A. W., Wotherspoon, A. C., . . . Tait, D. M. (2006). MRI in predicting curative resection of rectal cancer – New dilemma in multidisciplinary team management. BMJ-BRITISH MEDICAL JOURNAL, 333(7572), 808. doi:10.1136/bmj.333.7572.808

Brown, G., Daniels, I. R., Heald, R. J., Quirke, P., Blomqvist, L., Sebag-Montefiore, D., . . . Mason, B. (2006). Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BRITISH MEDICAL JOURNAL, 333(7572), 779-782. doi:10.1136/bmj.38937.646400.55

Chau, I., Cunningham, D., Tait, D., & Brown, G. (2006). Role of neoadjuvant chemotherapy in rectal cancer: Interpretation of the EXPERT study – Reply. JOURNAL OF CLINICAL ONCOLOGY, 24(28), 4665-4666. doi:10.1200/JCO.2006.08.2206

Salerno, G., Daniels, I. R., & Brown, G. (2006). Magnetic resonance imaging of the low rectum: defining the radiological anatomy. COLORECTAL DISEASE, 8, 10-13. doi:10.1111/j.1463-1318.2006.01063.x

Daniels, I. R., Fisher, S. E., Brown, G., Heald, R. J., & Moran, B. J. (2006). Complexities and controversies in the management of low rectal cancer: Proceedings of the 3rd Pelican Surgical Symposium 2005. COLORECTAL DISEASE, 8, 3-4. doi:10.1111/j.1463-1318.2006.01061.x

Koh, D. M., Scurr, E., Collins, D. J., Pirgon, A., Kanber, B., Karanjia, N., . . . Husband, J. E. (2006). Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. EUROPEAN RADIOLOGY, 16(9), 1898-1905. doi:10.1007/s00330-006-0201-x

Burton, S., Norman, A. R., Brown, G., Abulafi, A. M., & Swift, R. I. (2006). Predictive poor prognostic factors in colonic carcinoma. SURGICAL ONCOLOGY-OXFORD, 15(2), 71-78. doi:10.1016/j.suronc.2006.08.003

Chong, G., Starling, N., Norman, A. R., Brown, G., Thomas, J., Ross, P. J., & Cunningham, D. C. (2006). Phase II study of fixed dose rate gemcitabine in patients with pretreated advanced colorectal cancer.. J Clin Oncol, 24(18_suppl), 13558. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27952203

Rutten, H., Sebag-Montefiore, D., Glynne-Jones, R., Rullier, E., Peeters, M., Brown, G., . . . Quirke, P. (2006). Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 24 (pp. 153S). Atlanta, GA: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009401046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Rutten, H., Sebag-Montefiore, D., Glynne-Jones, R., Rullier, E., Peeters, M., Brown, G., . . . Quirke, P. (2006). Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: Results of an international multicenter phase II study.. J Clin Oncol, 24(18_suppl), 3528. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27953296

Pitt-Francis, J., Chen, D., Slaymaker, M., Simpson, A., Brady, M., van Leeuwen, I., . . . Gavaghan, D. (2006). Multimodal imaging techniques for the extraction of detailed geometrical and physiological information for use in multi-scale models of colorectal cancer and treatment of individual patients. Computational and Mathematical Methods in Medicine, 7(2-3), 177-188. doi:10.1080/10273660600969083

Burton, S., Brown, G., Daniels, I., Norman, A., Swift, I., Abulafi, M., . . . Tait, D. (2006). MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: Treatment with radiotherapy and chemotherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 65(2), 445-451. doi:10.1016/j.ijrobp.2005.12.027

Burton, S., Brown, G., Daniels, I. R., Norman, A. R., Mason, B., & Cunningham, D. (2006). MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. BRITISH JOURNAL OF CANCER, 94(3), 351-357. doi:10.1038/sj.bjc.6602947

Chan, I., Brown, G., Cunningham, D., Tait, D., Wotherspoon, A., Norman, A. R., . . . Oates, J. (2006). Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. JOURNAL OF CLINICAL ONCOLOGY, 24(4), 668-674. doi:10.1200/JCO.2005.04.4875

Riddell, A., Allum, W., Thompson, J., Wotherspoon, A., Cunningham, D., & Brown, G. (2006). The impact of high resolution MRI for determining operability of esophageal cancer. In ANNALS OF ONCOLOGY Vol. 17 (pp. 90). Barcelona, SPAIN: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

O’Neill, B. D. P., Brown, G., & Tait, D. M. (2006). Successful downstaging of upper rectal and distal sigmoid tumours by preoperative chemo-radiotherapy. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Vol. 66 (pp. S302). Philadelphia, PA: ELSEVIER SCIENCE INC. doi:10.1016/j.ijrobp.2006.07.570

Smith, N., Norman, A., Swift, I., & Brown, G. (2006). MRI detects extra-mural vascular invasion and predicts outcome in colorectal cancer. In ANNALS OF ONCOLOGY Vol. 17 (pp. 24-25). Barcelona, SPAIN: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Salerno, G., Daniels, I., & Brown, G. (2006). Low rectal cancers at the intersphincteric plane are at high risk of close resection margins: An analysis of the mercury study MRI scans. In ANNALS OF ONCOLOGY Vol. 17 (pp. 45-46). Barcelona, SPAIN: OXFORD UNIV PRESS. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Petroudi, S., Brown, G., Bond, S., & Brady, M. (2006). Circumferential resection margin assessment on MRI of rectal cancer.. Conf Proc IEEE Eng Med Biol Soc, 1, 4881-4884. doi:10.1109/IEMBS.2006.259277

Petroudi, S., Brown, G., Bond, S., & Brady, M. (2006). Circumferential resection margin assessment on MRI of rectal cancer. In 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15 (pp. 3851-+). New York, NY: IEEE. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247284704116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

2005

Brown, G., & Zbar, A. P. (2005). MRI in colorectal surgery: Surface magnetic resonance imaging in anorectal practice. In Complex Anorectal Disorders: Investigation and Management (pp. 275-297). doi:10.1007/1-84628-057-5_17

Sebag-Montefiore, D., Brown, G., Rutten, H., Rullier, E., Peeters, M., Glynne-Jones, R., . . . Van de Velde, C. (2005). An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results. EJC SUPPLEMENTS, 3(2), 170. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247564800586&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Koh, D. M., Brown, G., Temple, L., Blake, H., Raja, A., Toomey, P., . . . Husband, J. E. (2005). Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. EUROPEAN RADIOLOGY, 15(8), 1650-1657. doi:10.1007/s00330-005-2751-8

Assersohn, L., Norman, A. R., Chong, G., Brown, G., Ross, P. J., Costello, C., . . . Cunningham, D. (2005). Phase II trial evaluating capecitabine and irinotecan in patients (pts) with esophago-gastric (E-G) carcinoma having progressed or relapsed within 3 months of platinum-based chemotherapy.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 23 (pp. 350S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326602221&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Starling, N., Brown, G., Tait, D., Norman, A., & Cunningham, D. (2005). Patterns of pelvic recurrence in patients with rectal cancers treated with adjuvant chemotherapy in a multicentre randomised study.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 23 (pp. 271S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601496&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G., Daniels, I. R., Richardson, C., Revell, P., Peppercorn, D., & Bourne, M. (2005). Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. BRITISH JOURNAL OF RADIOLOGY, 78(927), 245-251. doi:10.1259/bjr/33540239

Brown, G., Daniels, I. R., & Quirke, P. (2005). MRI predicts surgical resection margin status in patients with rectal cancer. – Results from the MERCURY study group. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 13). London, ENGLAND: JOHN WILEY & SONS LTD. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000227614000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Daniels, I. R., Brown, G., & Quirke, P. (2005). High spatial resolution MRI predicts tumour spread in patients with rectal cancer – Results from the MERCURY study group. In JOURNAL OF PATHOLOGY Vol. 205 (pp. 13). London, ENGLAND: JOHN WILEY & SONS LTD. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000227614000053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G. (2005). Thin section MRI in multidisciplinary pre-operative decision making for patients with rectal cancer. BRITISH JOURNAL OF RADIOLOGY, 78, S117-S127. doi:10.1259/bjr/15128198

Brown, G., & Daniels, I. R. (2005). Preoperative staging of rectal cancer: the MERCURY research project.. Recent Results Cancer Res, 165, 58-74. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15865021

2004

Salerno, G., Daniels, I., Heald, R. J., Brown, G., & Moran, B. J. (2004). Management and imaging of low rectal carcinoma. SURGICAL ONCOLOGY-OXFORD, 13(2-3), 55-61. doi:10.1016/j.suronc.2004.09.013

Burton, S., Daniels, I., Brown, G., Stellakis, M., Chau, I., Swift, I. R., . . . Cunningham, D. (2004). Evaluation of the role of MRI in staging rectal cancer within the multidisciplinary team setting.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 22 (pp. 272S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512401079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Burton, S., Daniels, I., Brown, G., Stellakis, M., Chau, I., Swift, I. R., . . . Cunningham, D. (2004). Evaluation of the role of MRI in staging rectal cancer within the multidisciplinary team setting.. J Clin Oncol, 22(14_suppl), 3611. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28014328

Brown, G., Davies, S., Williams, G. T., Bourne, M. W., Newcombe, R. G., Radcliffe, A. G., . . . Maughan, T. S. (2004). Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. BRITISH JOURNAL OF CANCER, 91(1), 23-29. doi:10.1038/sj.bjc.6601871

Salerno, G., Daniels, I., Croxford, M., Brown, G., & Heald, R. J. (2004). Preoperative radiotherapy for rectal cancer. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 97(7), 361-362. doi:10.1258/jrsm.97.7.361-b

Blomqvist, L. (2004). Colorectal cancer imaging. AMERICAN JOURNAL OF ROENTGENOLOGY, 182(6), 1600-1601. doi:10.2214/ajr.182.6.1821600a

Chau, I., Allen, M. J., Cunningham, D., Norman, A. R., Brown, G., Ford, H. E. R., . . . Oates, J. (2004). The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY, 22(8), 1420-1429. doi:10.1200/JCO.2004.05.041

Koh, D. M., Brown, G., Temple, L., Raja, A., Toomey, P., Bett, N., . . . Husband, J. E. (2004). Rectal cancer: Mesorectal lymph nodes at MR Imaging with USPIO versus histopathologic findings – Initial observations. RADIOLOGY, 231(1), 91-99. doi:10.1148/radiol.2311030142

Brown, G. (2004). Local radiological staging of rectal cancer. CLINICAL RADIOLOGY, 59(3), 213-214. doi:10.1016/j.crad.2003.10.001

Snelling, J. D., Abdullah, N., Brown, G., King, D. M., Moskovic, E., & Gui, G. P. H. (2004). Measurement of tumour size in case selection for breast cancer therapy by clinical assessment and ultrasound. EJSO, 30(1), 5-9. doi:10.1016/j.ejso.2003.10.003

Snelling, J. D., Abdullah, N., Brown, G., King, D. M., Moskovic, E., & Gui, G. P. H. (2004). Measurement of tumour size in case selection for breast cancer therapy by clinical assessment and ultrasound. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 30(1), 5-9. doi:10.1016/j.ejso.2003.10.003

Brown, G., Kirkham, A., Williams, G. T., Bourne, M., Radcliffe, A. G., Sayman, J., . . . Heald, R. J. (2004). High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AMERICAN JOURNAL OF ROENTGENOLOGY, 182(2), 431-439. doi:10.2214/ajr.182.2.1820431

Assersohn, L., Brown, G., Cunningham, D., Ward, C., Oates, J., Waters, J. S., . . . Norman, A. R. (2004). Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. ANNALS OF ONCOLOGY, 15(1), 64-69. doi:10.1093/annonc/mdh007

Heald, R. J., Moran, B. J., Brown, G., & Daniels, I. R. (2004). Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers’ fascia. BRITISH JOURNAL OF SURGERY, 91(1), 121-123. doi:10.1002/bjs.4386

2003

Brown, G. (2003). Imaging of the liver in metastatic disease. EJC SUPPLEMENTS, 1(6), 159-171. doi:10.1016/S1359-6349(03)90020-6

Chau, I., Cunningham, D., Tait, D., Brown, G., Tebbutt, N., Hill, M., . . . Massey, A. (2003). Twelve weeks of neoadjuvant capecitabine (cap) and oxaliplatin (ox) followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief. In BRITISH JOURNAL OF CANCER Vol. 88 (pp. S20). BOURNEMOUTH, ENGLAND: NATURE PUBLISHING GROUP. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000184042200075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Brown, G., Richards, C. J., Bourne, M. W., Newcombe, R. G., Radcliffe, A. G., Dallimore, N. S., & Williams, G. T. (2003). Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. RADIOLOGY, 227(2), 371-377. doi:10.1148/radiol.2272011747

Chau, I., Allen, M., Cunningham, D., Tait, D., Brown, G., Hill, M., . . . Prior, Y. (2003). Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. BRITISH JOURNAL OF CANCER, 88(7), 1017-1024. doi:10.1038/sj.bjc.6600822

Brown, G., Radcliffe, A. G., Newcombe, R. G., Dallimore, N. S., Bourne, M. W., & Williams, G. T. (2003). Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. BRITISH JOURNAL OF SURGERY, 90(3), 355-364. doi:10.1002/bjs.4034

Chau, I., Kelleher, M. T., Cunningham, D., Norman, A. R., Wotherspoon, A., Trott, P., . . . Bishop, L. (2003). Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. BRITISH JOURNAL OF CANCER, 88(3), 354-361. doi:10.1038/sj.bjc.6600738

2002

Brown, G., Drury, A. E., Cunningham, D., & Husband, J. E. S. (2003). CT detection of hydronephrosis in resected colorectal cancer: a predictor of recurrent disease. CLINICAL RADIOLOGY, 58(2), 137-142. doi:10.1053/crad.2002.1123

Tan, S. M., Behranwala, K. A., Trott, P. A., Nasim, N. A., Moskovic, E., Brown, G., . . . Gui, G. P. H. (2002). Erratum: A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma (European Journal of Surgical Oncology (2002) vol. 28 (203-8)). European Journal of Surgical Oncology, 28(8), 900. doi:10.1053/ejso.2002.1368

Bartram, C., & Brown, G. (2002). Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 31(3), 827-+. doi:10.1016/S0889-8553(02)00027-4

Dzik-Jurasz, A., Domenig, C., George, M., Wolber, J., Padhani, A., Brown, G., & Doran, S. (2002). Diffusion MRI for prediction of response of rectal cancer to chemoradiation. LANCET, 360(9329), 307-308. doi:10.1016/S0140-6736(02)09520-X

Tan, S. M., Behranwala, K. A., Trott, P. A., Nasim, N. A., Moskovic, E., Brown, G., . . . Gui, G. P. H. (2002). A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 28(3), 203-208. doi:10.1053/ejso.2001.1236

2001

Tan, S. M., Behranwala, K. A., Nasiri, N., Trott, P. A., King, D. M., Moskovic, E., . . . Gui, G. P. H. (2001). Triple assessment in the preoperative diagnosis of invasive tabular breast carcinoma: A comparison of the individual modalities. Breast Cancer Research and Treatment, 69(3), 297.

Whitehouse, P. A., Barber, Y., Brown, G., Moskovic, E., King, D. M., & Gui, G. P. H. (2001). Office ultrasound by breast surgeons: A rapid, accurate adjunct to clinical diagnosis. Breast Cancer Research and Treatment, 69(3), 237.

George, M. L., Dzik-Jurasz, A. S. K., Padhani, A. R., Brown, G., Tait, D. M., Eccles, S. A., & Swift, R. I. (2001). Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. BRITISH JOURNAL OF SURGERY, 88(12), 1628-1636. doi:10.1046/j.0007-1323.2001.01947.x

George, M. L., Dzik-Jurasz, A. S. K., Brown, G., Padhani, A. R., Husband, J., Leach, M. O., . . . Swift, R. I. (2001). Dynamic contrast MRI (DCMRI) assessment of tumour permeability in locally advanced rectal cancer: a prognostic indicator for response to chemoradiotherapy. BRITISH JOURNAL OF SURGERY, 88, 25. Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168603000077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Radcliffe, A., & Brown, G. (2001). Will MRI provide maps of lines of excision for rectal cancer?. LANCET, 357(9255), 495-496. doi:10.1016/S0140-6736(00)04038-1

Whitehouse, P. A., Baber, Y., Brown, G., Moskovic, E., King, D. M., & Gui, G. P. H. (2001). The use of ultrasound by breast surgeons in outpatients: an accurate extension of clinical diagnosis. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 27(7), 611-616. doi:10.1053/ejso.2001.1201

2000

Brown, G. (2000). The role of MRI in the local staging of rectal cancer. In Cancer Imaging Vol. 1 (pp. 7-10).

Brown, G. (2000). CT patterns of recurrent disease in colorectal cancer. In Cancer Imaging Vol. 1 (pp. 14-17).

Brown, G. (2000). The role of MRI in the pre-operative staging of rectal cancer. Imaging, 12(2), 141-150. doi:10.1259/img.12.2.120141

1999

Brown, G., Richards, C. J., Newcombe, R. G., Dallimore, N. S., Radcliffe, A. G., Carey, D. P., . . . Williams, G. T. (1999). Rectal carcinoma: Thin-section MR imaging for staging in 28 patients. RADIOLOGY, 211(1), 215-222. doi:10.1148/radiology.211.1.r99ap35215

Brown, G., Phillips, S., Cochlin, D., Bourne, M. W., & Jenkins, B. (1997). Dynamic magnetic resonance imaging of the testis: Preliminary results. British Journal of Urology, 79(SUPPL. 4), 20.

BROWN, G., & SHAW, D. G. (1995). INFLAMMATORY PSEUDOTUMORS IN CHILDREN – CT AND ULTRASOUND APPEARANCES WITH HISTOPATHOLOGICAL CORRELATION. CLINICAL RADIOLOGY, 50(11), 782-786. doi:10.1016/S0009-9260(05)83220-9

BROWN, G., MACVICAR, D. A., AYTON, V., & HUSBAND, J. E. (1995). THE ROLE OF INTRAVENOUS CONTRAST ENHANCEMENT IN MAGNETIC-RESONANCE-IMAGING OF PROSTATIC-CARCINOMA. CLINICAL RADIOLOGY, 50(9), 601-606. doi:10.1016/S0009-9260(05)83288-X

Schon, F., Brown, G., & Britton, J. (1995). Tuberculous myelopathy: a serial MRI study.. J Neurol Neurosurg Psychiatry, 58(2), 259-260. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7876874

BROWN, G., WARREN, M., WILLIAMS, J. E., ADAM, E. J., & COLES, J. A. (1993). CRANIAL COMPUTED-TOMOGRAPHY OF ELDERLY PATIENTS – AN EVALUATION OF ITS USE IN ACUTE NEUROLOGICAL PRESENTATIONS. AGE AND AGEING, 22(4), 240-243. doi:10.1093/ageing/22.4.240

BROWN, G., & HUSBAND, J. E. (1993). MEDIASTINAL WIDENING – A VALUABLE RADIOGRAPHIC SIGN OF SUPERIOR VENA-CAVA THROMBOSIS. CLINICAL RADIOLOGY, 47(6), 415-420. doi:10.1016/S0009-9260(05)81063-3